Insomnia

F5_INSOMNIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — F51.0, G47.0 Hospital discharge: ICD-10 — F51.0, G47.0 Cause of death: ICD-10 — F51.0, G47.0 3 out of 7 registries used, show all original rules.	53896
4. Check minimum number of events None	53896
5. Include endpoints None	53896
6. Filter based on genotype QC (FinnGen only)	51643

Control definitions (FinnGen only)

Control exclude: F5_SLEEP

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_INSOMNIA
CONTROL_EXCLUDE	F5_SLEEP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	F510\|G470
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F510\|G470
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F510\|G470
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Insomnia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	51643	36693	14950
Unadjusted period prevalence (%)	11.23	13.02	6.85
Median age at first event (years)	52.50	51.22	55.62

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
52660: Matched controls
383512

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01AA02

ATC

doxycycline; systemic

1.5

322.6

37283

238482

K30

ICD-10 Finland

Functional dyspepsia

1.8

322.5

5523

23221

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

318.5

14937

80622

F43.2

ICD-10 Finland

Adjustment disorders

3.7

318.2

1138

2282

SFA20

NOMESCO Finland

Two-surface restoration

1.4

317.8

29634

181830

-1, ,

ICD-10 Finland

2.3

316.9

2671

8651

R00.2

ICD-10 Finland

Palpitations

2.0

310.4

3991

15258

L03

ICPC

Low back symptom/complaint

1.7

307.7

14631

69472

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

22410

114901

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

13793

63928

KMAK, ,

NOMESCO Finland

1.5

307.7

26269

155183

F32

ICD-10 Finland

Depressive episode

3.6

307.7

4425

9526

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

307.7

6150

25182

G47.3

ICD-10 Finland

Sleep apnoea

1.6

307.7

10182

49945

F51

ICD-10 Finland

Nonorganic sleep disorders

7.0

307.7

4603

5204

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

307.7

6552

20237

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

307.7

6507

25340

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

307.7

47322

315485

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.1

307.7

1860

3395

N06BA04

ATC

methylphenidate; oral

2.9

307.7

2122

5450

F43.01

ICD-10 Finland

Acute stress reaction moderate

3.9

307.7

1113

2134

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

30584

186178

OAB91, ,

SPAT

2.7

307.7

4359

12245

D11

ICPC

Diarrhoea

2.1

307.7

6981

26465

N05CF02

ATC

zolpidem; oral

4.2

307.7

15088

33138

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

13583

67508

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

307.7

3627

11954

N05AH04

ATC

quetiapine; oral

5.1

307.7

17431

34086

F32.1

ICD-10 Finland

Moderate depressive episode

3.6

307.7

4936

10654

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

307.7

10228

43615

N06AB06

ATC

sertraline; oral

2.7

307.7

7846

23282

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

307.7

20442

98713

A02BC05

ATC

esomeprazole; systemic

1.5

307.7

19129

105202

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

307.7

11828

58227

N06AB03

ATC

fluoxetine; oral

2.4

307.7

7234

24325

N06AX26

ATC

vortioxetine; oral

3.4

307.7

5869

13534

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

307.7

8711

41286

N06AX22

ATC

agomelatine; oral

4.6

307.7

1879

3050

Z73.0

ICD-10 Finland

Burn-out

5.1

307.7

3515

5312

D10

ICPC

Vomiting

2.1

307.7

3521

12472

R01AD09

ATC

mometasone; nasal

1.6

307.7

23644

131907

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

5.6

307.7

3513

4803

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

29098

169361

N06AX21

ATC

duloxetine; oral

2.6

307.7

7434

23207

N06AX11

ATC

mirtazapine; oral

7.7

307.7

33660

71997

P01

ICPC

Feeling anxious/nervous/tense

3.1

307.7

10263

27918

SPAT1283

SPAT

Restricted health certificate

1.9

307.7

11251

47304

OAB48, ,

SPAT

1.8

307.7

8282

36497

N01

ICPC

Headache

2.0

307.7

6633

26007

R21

ICPC

Throat symptom/complaint

1.7

307.7

12405

57790

N05BA12

ATC

alprazolam; oral

2.4

307.7

5520

18063

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.9

307.7

2517

4851

R03AC02

ATC

salbutamol; inhalant

1.7

307.7

28768

160808

F41

ICD-10 Finland

Other anxiety disorders

4.0

307.7

1225

2271

N03AX16

ATC

[U] pregabalin

1.8

307.7

11355

51484

Z05

ICPC

Work problem

3.4

307.7

2009

4420

M01AH05

ATC

etoricoxib; oral

1.6

307.7

31680

183401

N04BC05

ATC

pramipexole; oral

2.3

307.7

3529

11731

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

307.7

9021

39821

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

307.7

4091

13298

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

307.7

6244

17198

P74

ICPC

Anxiety disorder/anxiety state

3.2

307.7

3140

7480

P02

ICPC

Acute stress reaction

3.6

307.7

4287

9219

N07BB01

ATC

disulfiram; oral

2.6

307.7

2361

6748

M54.5

ICD-10 Finland

Low back pain

2.0

307.7

20708

94560

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.8

307.7

5650

23760

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

22671

110821

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.1

307.7

2515

6169

N06AA09

ATC

amitriptyline; systemic

2.1

307.7

4397

16306

R06.0

ICD-10 Finland

Dyspnoea

1.6

307.7

11715

59436

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.4

307.7

1458

3146

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

4875

R74

ICPC

Upper respiratory infection acute

1.9

307.7

19444

91628

R01AD12

ATC

fluticasone furoate; nasal

1.6

307.7

17068

87436

N03AX12

ATC

[U] gabapentin; oral

1.8

307.7

7745

33935

L01

ICPC

Neck symptom/complaint

1.8

307.7

8050

35175

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

22268

120401

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

307.7

30754

152305

N06AX05

ATC

trazodone; oral

6.1

307.7

2179

2711

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

32839

197797

OAB43, ,

SPAT

2.1

307.7

19479

84051

J01DB01

ATC

cefalexin; oral

1.6

307.7

42233

275010

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

307.7

14336

69927

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

9354

40258

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

9.4

307.7

474

369

A03

ICPC

Fever

1.6

307.7

9012

42672

G43

ICD-10 Finland

Migraine

2.6

307.7

3429

10035

SPAT1240

SPAT

Therapeutic discussion

2.5

307.7

7423

23665

F33

ICD-10 Finland

Recurrent depressive disorder

4.1

307.7

1729

3154

OAB93, ,

SPAT

3.5

307.7

4730

10539

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.2

307.7

1832

4334

N06AB04

ATC

citalopram; systemic

2.3

307.7

12500

44997

J02AC01

ATC

fluconazole; systemic

1.6

307.7

20306

109936

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

307.7

4154

10081

N05AA02

ATC

levomepromazine; systemic

3.2

307.7

2264

5269

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.6

307.7

4363

9460

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

3.9

307.7

2043

3889

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.3

307.7

1838

4139

N89

ICPC

Migraine

2.6

307.7

2183

6196

P25

ICPC

Phase of life problem adult

2.5

307.7

2585

7772

P76

ICPC

Depressive disorder

2.9

307.7

4767

12757

N03AX09

ATC

lamotrigine; oral

2.4

307.7

2820

8805

N06AA06

ATC

trimipramine; systemic

4.9

307.7

1631

2493

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.2

307.7

1464

3395

N05CF01

ATC

zopiclone; oral

4.0

307.7

23665

65633

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.7

307.7

12026

56657

OAA81, ,

SPAT

3.1

307.7

2106

5049

N02BE01

ATC

paracetamol; systemic, rectal

2.0

307.7

45831

296076

C07AA05

ATC

propranolol; systemic

2.3

307.7

12803

47639

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

17148

82576

N05BA04

ATC

oxazepam; oral

3.3

307.7

19002

56739

R01AD58

ATC

fluticasone, combinations; nasal

1.7

307.7

13639

65302

N76.0

ICD-10 Finland

Acute vaginitis

2.1

307.7

3694

13106

N05CD07

ATC

temazepam; oral

2.7

307.7

5909

17429

N06AA12

ATC

doxepin; systemic

3.2

307.7

2825

6670

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

17266

81061

F43.8

ICD-10 Finland

Other reactions to severe stress

4.2

307.7

2072

3693

F43.00

ICD-10 Finland

Acute stress reaction mild

3.2

307.7

1615

3761

M79.1

ICD-10 Finland

Myalgia

1.9

307.7

7760

32170

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

307.7

2787

7130

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

307.7

1887

4842

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

307.7

3276

8053

N06AB05

ATC

paroxetine; oral

2.4

307.7

3365

10459

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

4.4

307.7

1621

2756

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.3

307.7

1608

3638

N05AH03

ATC

olanzapine; systemic

2.6

307.7

3778

11256

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.8

307.7

2430

4767

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.0

307.7

9646

20233

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

13673

59744

R53

ICD-10 Finland

Malaise and fatigue

2.3

307.7

14578

54872

A98

ICPC

Health maint/preventive medicine

3.4

307.7

51542

357420

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.9

307.7

2085

5320

R83

ICPC

Respiratory infection other

1.7

307.7

14738

72849

R42

ICD-10 Finland

Dizziness and giddiness

1.6

307.7

10105

49776

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

9.4

307.7

2167

1750

M03BX02

ATC

tizanidine; oral

1.8

307.7

33587

187374

R06AE07

ATC

cetirizine; oral

1.4

307.7

22183

128368

F43.0

ICD-10 Finland

Acute stress reaction

4.3

307.7

4912

9061

P29

ICPC

Psychological sympt/compl other

2.8

307.7

5003

14042

N06AX12

ATC

bupropion; oral

3.0

307.7

5382

13997

P06

ICPC

Sleep disturbance

5.2

307.7

11901

20380

J01FA10

ATC

azithromycin; systemic

1.5

307.7

29814

180559

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.9

307.7

1932

5017

D01

ICPC

Abdominal pain/cramps general

1.8

307.7

6271

26145

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

12468

55121

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

307.7

5088

18483

N06AX16

ATC

venlafaxine; oral

2.8

307.7

10332

30376

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

307.7

2581

7316

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

307.7

14109

55099

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

307.7

10773

53657

M54

ICD-10 Finland

Dorsalgia

2.0

307.7

7147

27474

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

307.7

10603

27183

A04

ICPC

Weakness/tiredness general

2.0

307.7

7890

31731

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

307.7

3409

11696

R51.80

ICD-10 Finland

Headache

2.1

307.7

9306

35680

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.6

307.7

3281

7018

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

100.2

307.7

301

R06AX27

ATC

desloratadine; oral

1.6

307.7

15062

78637

G44.2

ICD-10 Finland

Tension-type headache

2.1

307.7

8145

30234

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

307.7

5546

23194

A02BC02

ATC

pantoprazole; systemic

1.6

307.7

33073

196962

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

307.7

3613

11050

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

307.7

38612

235335

N06AB10

ATC

escitalopram; oral

2.9

307.7

15788

48915

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

28127

166334

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

307.7

5606

17621

N06AX03

ATC

mianserin; oral

3.7

307.7

2996

6129

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

42305

276550

R51

ICD-10 Finland

Headache

2.4

307.7

3299

10598

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

307.7

36715

229844

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.0

307.7

4741

12372

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

24210

138291

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

24843

143524

F34.1

ICD-10 Finland

Dysthymia

3.1

307.7

2302

5650

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

49760

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.3

307.7

1803

4025

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

19168

108298

F32.0

ICD-10 Finland

Mild depressive episode

3.3

307.7

1842

4198

N05BA01

ATC

diazepam; systemic, rectal

2.2

307.7

6962

24457

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.0

307.7

9201

19246

P03

ICPC

Feeling depressed

2.8

307.7

7654

21839

OAA65, ,

SPAT

2.9

307.7

13032

39190

N02AX02

ATC

tramadol; systemic, rectal

1.6

307.7

20157

108671

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

307.7

8034

32443

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

307.7

35042

218557

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.5

307.7

1599

3370

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.6

307.7

3630

7660

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

2.1

307.3

3490

12752

ZY010

NOMESCO Finland

Hospital outpatient

2.2

305.8

2794

9364

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

304.8

26323

158786

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

304.8

1650

4293

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.0

301.0

3972

15319

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

300.4

3850

14697

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

299.7

13479

71954

SFA10

NOMESCO Finland

One-surface restoration

1.4

299.4

27653

168555

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

299.0

1556

3959

R05

ICPC

Cough

1.5

298.8

11382

58682

IHZ05, ,

SPAT

2.4

298.6

2308

7187

N03AE01

ATC

clonazepam; systemic

2.2

294.8

2696

9036

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

292.5

12033

63012

Z01.2

ICD-10 Finland

Dental examination

1.4

292.1

22846

135051

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.8

290.5

1645

4386

N05BE01

ATC

buspirone; oral

2.9

289.3

1546

3992

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.7

288.9

1046

2115

L02

ICPC

Back symptom/complaint

1.8

287.5

5078

21507

R05

ICD-10 Finland

Cough

1.6

287.4

9778

49111

Z01.7

ICD-10 Finland

Laboratory examination

1.7

279.8

6858

31810

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

6.8

279.5

503

542

P15

ICPC

Chronic alcohol abuse

2.8

279.5

1565

4146

X23

ICPC

Fear sexually transm dis female

2.1

278.4

2945

10461

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.0

278.3

1373

3386

L17

ICPC

Foot/toe symptom/complaint

1.5

277.6

13027

69934

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.4

274.5

1125

2474

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

274.4

2993

10756

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

270.7

4419

18252

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.2

266.8

1158

2642

GD1AA, ,

SPAT

1.7

266.4

6003

27208

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.9

265.6

3930

15726

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

264.4

10970

57352

N02BF02

ATC

pregabalin; oral

2.1

262.9

2816

10046

D73

ICPC

Gastroenteritis presumed infection

2.4

258.5

1983

6147

SPAT1308

SPAT

Sexual health counselling

1.6

257.9

6562

30677

R52.9

ICD-10 Finland

Pain, unspecified

1.8

255.8

4623

19678

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.7

255.7

1569

4362

J01CA08

ATC

pivmecillinam; oral

1.4

255.1

19416

113380

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

255.0

34316

219890

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

252.1

25570

156372

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.9

248.5

1283

3247

M54.2

ICD-10 Finland

Cervicalgia

1.9

248.5

3747

15074

SPAT1051

SPAT

Guidance regarding sleep disorders

3.6

248.5

928

1917

P99

ICPC

Psychological disorders other

2.6

248.2

1650

4776

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

247.1

1458

3971

R11

ICD-10 Finland

Nausea and vomiting

1.8

245.3

4025

16629

N30

ICD-10 Finland

Cystitis

1.8

245.0

4006

16531

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

244.6

3668

14726

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

244.1

9735

50366

N05AX12

ATC

aripiprazole; systemic

2.2

239.1

2223

7489

N05AF03

ATC

chlorprothixene; systemic

2.8

238.3

1348

3589

S06.0

ICD-10 Finland

Concussion

1.7

236.8

5010

22278

R01AD08

ATC

fluticasone; nasal

1.4

236.5

13562

75168

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.6

236.4

5888

27332

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

234.2

1573

4575

N06AG02

ATC

moclobemide; oral

2.3

232.6

1960

6332

N30.0

ICD-10 Finland

Acute cystitis

1.6

232.6

7474

36863

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

232.4

3597

14581

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

230.7

5463

25022

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

230.6

9319

48271

-1, ,

NOMESCO Finland

1.4

230.6

16391

94192

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.0

227.6

1135

2815

D09

ICPC

Nausea

2.1

227.3

2453

8765

R12

ICD-10 Finland

Heartburn

1.8

226.6

3807

15826

P58

ICPC

Psychological, Therapeutic counselling/listening

2.9

225.8

1186

3030

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

102.9

224.5

155

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

224.3

5651

26284

R03DC03

ATC

montelukast; oral

1.5

223.8

7696

38501

K08.80

ICD-10 Finland

Toothache NOS

1.7

223.5

4362

18948

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

20.0

222.9

213

J20

ICD-10 Finland

Acute bronchitis

1.7

222.5

4711

20932

O99.80

ICD-10 Finland

The fear of childbirth

2.1

222.3

2335

8255

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

221.9

19737

117381

J45

ICD-10 Finland

Asthma

1.7

221.8

4827

21607

N03AG01

ATC

valproic acid; systemic, rectal

2.0

219.2

2789

10582

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

219.1

19878

118510

M79.7

ICD-10 Finland

Fibromyalgia

2.3

216.2

1768

5635

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.4

216.0

884

1941

N02BF01

ATC

gabapentin; oral

1.8

215.9

3597

14907

A01

ICPC

Pain general/multiple sites

1.8

214.6

3995

17112

A02BC03

ATC

lansoprazole; oral

1.4

212.8

11927

65607

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

212.7

3698

15523

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.0

212.5

1072

2676

L08

ICPC

Shoulder symptom/complaint

1.5

212.5

9376

49324

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.2

212.4

955

2226

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

211.2

2832

10939

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

209.7

5461

25582

N02CC07

ATC

frovatriptan; oral

2.1

209.6

2088

7227

L12

ICPC

Hand/finger symptom/complaint

1.5

208.6

7401

37221

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

208.4

18269

108093

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.4

204.0

836

1837

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

203.6

5790

27690

M77.1

ICD-10 Finland

Lateral epicondylitis

1.8

203.1

3791

16240

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.5

203.1

9383

49746

R07

ICPC

Sneezing/nasal congestion

1.8

202.3

3380

14010

A02BC01

ATC

omeprazole; systemic

1.4

202.2

11498

63312

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.7

201.8

1163

3126

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

200.4

5275

24758

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.9

200.2

1015

2541

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

198.8

13917

79327

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

198.0

6787

33843

A05

ICPC

Feeling ill

1.8

197.0

3182

13049

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.9

196.5

1049

2704

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

196.4

8089

41901

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.4

195.5

10358

56271

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

195.0

8183

42537

R02

ICPC

Shortness of breath/dyspnoea

1.6

194.4

5482

26146

SPAT1192

SPAT

Gynaecological examination

1.6

193.8

4681

21493

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

193.3

952

2343

T74.1

ICD-10 Finland

Physical abuse

2.8

191.9

1076

2849

R07.0

ICD-10 Finland

Pain in throat

1.8

191.6

3479

14774

Z00.0

ICD-10 Finland

General medical examination

1.5

191.5

8527

44827

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

190.9

782

1718

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

190.8

4995

23394

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.8

189.5

1057

2791

Z2221

NOMESCO Finland

Medical doctor

1.4

188.7

12043

67497

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

188.4

2403

9114

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

188.2

3482

14865

F32.8

ICD-10 Finland

Other depressive episodes

3.0

188.0

903

2190

H02AB06

ATC

prednisolone; systemic

1.3

187.2

20917

127635

F40.1

ICD-10 Finland

Social phobias

2.4

187.2

1368

4140

R52.2

ICD-10 Finland

Other chronic pain

2.2

187.0

1673

5538

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

187.0

4968

23344

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

187.0

4198

18904

P16

ICPC

Acute alcohol abuse

3.1

186.9

863

2044

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

183.9

3265

13770

SPAT1310

SPAT

Counselling related to known health issue

1.4

183.3

14298

82685

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

183.1

9486

51240

H01

ICPC

Ear pain/earache

1.6

182.9

5499

26597

W12

ICPC

Contraception intrauterine

1.6

182.6

4559

21091

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.0

181.3

895

2206

D82

ICPC

Teeth/gum disease

1.3

180.9

17869

106982

Z2445

NOMESCO Finland

Psychologist

2.1

180.9

1911

6763

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

180.1

2988

12344

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.6

179.7

650

1313

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.8

178.9

2947

12148

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.8

177.1

2992

12428

J01EA01

ATC

trimethoprim; systemic

1.4

176.1

11216

62720

M01AC06

ATC

meloxicam; systemic, rectal

1.3

175.8

15320

89963

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.7

175.3

1070

2963

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

174.8

4171

19065

E0000UV, ,

ATC

1.3

174.7

19190

116457

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

174.1

9808

53704

R07.3

ICD-10 Finland

Other chest pain

1.6

173.9

4223

19390

SPAT1263

SPAT

Sampling

1.3

173.4

19279

117154

N06AB08

ATC

fluvoxamine; oral

2.5

172.8

1190

3500

OAA67, ,

SPAT

1.5

172.7

7275

37755

N05BA02

ATC

chlordiazepoxide; systemic

2.7

172.5

991

2658

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

2.0

172.1

2082

7746

R06AX22

ATC

ebastine; oral

1.4

172.0

7828

41227

U02

ICPC

Urinary frequency/urgency

1.5

171.6

6086

30494

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

171.0

11699

66132

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

170.7

18738

113591

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.6

169.4

4265

19753

J01

ICD-10 Finland

Acute sinusitis

1.8

169.0

2635

10673

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

168.5

2638

10700

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

167.9

2331

9094

A02BC04

ATC

rabeprazole; oral

1.7

167.8

3782

17027

N17

ICPC

Vertigo/dizziness

1.6

167.6

4962

23883

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.4

167.5

317

362

SGA01

NOMESCO Finland

Emergency treatment

1.4

167.1

7697

40606

J01DA01

ATC

[U] cefalexin

1.3

166.4

28713

184555

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.5

166.2

625

1297

D06

ICPC

Abdominal pain localized other

1.6

165.9

3940

17978

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.5

165.8

635

1334

K59.0

ICD-10 Finland

Constipation

1.9

165.5

2250

8715

SPAT1312

SPAT

General health counselling

1.3

165.3

14631

85936

K58

ICD-10 Finland

Irritable bowel syndrome

2.3

165.3

1333

4218

ZXE00

NOMESCO Finland

One hour or less

1.3

165.2

16992

101953

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.1

164.9

1782

6358

N05AX08

ATC

risperidone; systemic

1.7

164.7

3246

14091

L15

ICPC

Knee symptom/complaint

1.4

164.7

10179

56542

N06BA12

ATC

lisdexamfetamine; oral

3.7

164.4

590

1185

E66

ICD-10 Finland

Obesity

1.9

163.6

2417

9622

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

163.0

2514

10145

Z3231

NOMESCO Finland

Registered nurse

1.4

161.7

11379

64514

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.8

161.2

540

1032

J01FA06

ATC

roxithromycin; oral

1.3

160.7

17332

104565

P18

ICPC

Medication abuse

4.9

160.5

401

604

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

160.5

2751

11467

SDA03

NOMESCO Finland

Periodontal treatment

1.3

160.1

18778

114561

EB1AA, ,

SPAT

1.7

160.1

3015

12918

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

158.7

4176

19536

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

158.7

1700

6044

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

156.8

2270

8974

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.9

156.6

798

2003

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

156.5

2557

10504

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.9

155.8

817

2084

E66.8

ICD-10 Finland

Other obesity

1.8

155.8

2565

10561

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.6

155.7

570

1161

B02AA02

ATC

tranexamic acid; systemic

1.5

155.4

6421

33133

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

155.2

6075

31012

S18

ICPC

Laceration/cut

1.3

155.2

19259

118229

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

154.0

3555

16092

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

153.5

10638

60088

G03DB01

ATC

dydrogesterone; oral

1.5

153.0

5598

28183

N02CC04

ATC

rizatriptan; oral

1.8

152.4

2649

11083

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

152.4

3482

15718

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

152.3

3711

17027

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

152.0

4970

24429

M54.8

ICD-10 Finland

Other dorsalgia

1.9

151.9

2024

7783

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

151.6

1309

4266

F31

ICD-10 Finland

Bipolar affective disorder

3.1

151.0

689

1620

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

150.0

4146

19613

N02CC05

ATC

almotriptan; oral

2.0

150.0

1890

7129

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

149.2

1543

5411

K04.0

ICD-10 Finland

Pulpitis

1.6

148.8

4446

21412

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.6

148.8

4310

20612

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

148.7

3155

13962

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

148.4

4692

22887

F10.24

ICD-10 Finland

Alcohol depence active use

3.0

147.4

724

1779

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

147.0

3072

13538

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

146.8

3420

15510

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

146.8

15124

90399

R09

ICPC

Sinus symptom/complaint

1.6

146.6

3805

17727

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

146.2

1968

7593

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.5

145.8

1023

3035

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

145.6

1726

6369

EBA00

NOMESCO Finland

Extraction of tooth

1.3

145.3

16318

98633

D19

ICPC

Teeth/gum symptom/complaint

1.3

145.1

13047

76504

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

144.9

3981

18800

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.5

144.6

6273

32638

W11

ICPC

Contraception oral

1.5

144.5

4544

22131

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.6

144.4

4172

19933

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

143.3

7600

41013

H92.0

ICD-10 Finland

Otalgia

1.7

142.9

2787

12049

K04.08

ICD-10 Finland

Other specified pulpit

1.6

142.7

3566

16455

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

142.7

873

2420

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

142.5

13747

81357

LCH11

NOMESCO Finland

Pharmacologic abortion

2.0

142.5

1781

6697

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

141.9

739

1878

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

141.3

2811

12218

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.5

141.0

1013

3039

SFA30

NOMESCO Finland

Three-surface restoration

1.3

141.0

18753

115709

WX110, ,

SPAT

1.7

139.5

2683

11552

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.9

138.9

731

1869

M77.4

ICD-10 Finland

Metatarsalgia

1.7

138.6

2624

11247

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

138.5

5049

25365

G02BA03

ATC

plastic IUD with progestogen

1.5

138.4

5105

25707

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.5

138.1

925

2683

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

137.9

11751

68287

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

137.8

3500

16210

F51.1

ICD-10 Finland

Nonorganic hypersomnia

17.7

137.8

138

OAA62, ,

SPAT

1.6

137.6

3499

16210

G43.3

ICD-10 Finland

Complicated migraine

2.6

137.0

872

2466

R30.0

ICD-10 Finland

Dysuria

1.9

137.0

1817

6973

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.7

136.8

812

2216

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

136.6

805

2188

G01AA10

ATC

clindamycin; vaginal

1.4

135.8

6220

32666

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.7

135.7

797

2163

U01

ICPC

Dysuria/painful urination

1.6

135.5

3397

15680

SPAT1301

SPAT

No procedures

1.3

135.3

13308

78855

N02CC03

ATC

zolmitriptan; nasal, oral

1.8

135.0

2425

10238

N05AN01

ATC

lithium; oral

2.3

134.7

1121

3595

SPAT1260

SPAT

Consultation of another employee

1.4

134.6

7371

39952

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

134.0

2559

10994

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.8

133.9

2149

8770

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.8

133.8

2358

9899

ULA02

NOMESCO Finland

Kolposcopy

1.5

133.3

4145

20118

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

133.1

9330

52625

F41.00

ICD-10 Finland

Moderate panic disorder

2.6

132.6

822

2294

C09CA06

ATC

candesartan; oral

1.3

132.6

9655

54775

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.9

132.2

689

1752

K07.60

ICD-10 Finland

Snapping jaw

1.7

132.1

2424

10294

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

131.6

2545

10970

L16

ICPC

Ankle symptom/complaint

1.5

130.9

4908

24780

N07BA03

ATC

varenicline; oral

1.8

130.7

2132

8744

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.7

130.6

2873

12825

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.8

130.5

708

1841

Z2446

NOMESCO Finland

Social worker

1.7

130.0

2654

11613

S80.0

ICD-10 Finland

Contusion of knee

1.6

129.8

3279

15158

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

129.6

8180

45361

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.3

129.5

528

1157

AA1AD

NOMESCO Finland

CT of head and brain

1.3

129.0

10082

57765

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

129.0

5543

28741

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

129.0

3644

17300

N05CD02

ATC

nitrazepam; oral

3.1

128.9

592

1398

N02CC06

ATC

eletriptan; oral

1.9

128.8

1679

6403

DM1QA, ,

SPAT

1.9

128.7

1717

6600

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

128.6

3348

15591

R06AE09

ATC

levocetirizine; oral

1.4

128.5

6426

34259

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

128.5

14942

90368

R03BA02

ATC

budesonide; inhalant

1.4

128.1

7567

41505

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

127.9

15887

96873

N03AX11

ATC

topiramate; oral

2.2

127.6

1162

3871

Z12

ICPC

Relationship problem with partner

2.5

127.0

884

2613

G03HB01

ATC

cyproterone and estrogen; oral

1.5

126.6

4331

21449

J05AB01

ATC

aciclovir; systemic

1.3

126.3

9191

52083

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.5

125.9

3992

19447

H03AA01

ATC

levothyroxine sodium; systemic

1.3

125.6

9698

55436

R03BA05

ATC

fluticasone; inhalant

1.4

125.6

7834

43338

W14

ICPC

Contraception female other

1.7

125.1

2386

10242

J30.19

ICD-10 Finland

Pollen allergy UNS

1.9

124.9

1827

7239

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

124.6

945

2907

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

124.5

11976

70593

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.4

124.4

974

3040

S29

ICPC

Skin symptom/complaint other

1.4

124.1

7765

42967

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.7

124.1

719

1937

A11

ICPC

Chest pain NOS

1.6

124.0

3070

14116

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

123.8

3339

15675

J01AA07

ATC

tetracycline; systemic

1.4

123.6

6609

35627

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.5

123.4

4079

20049

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

122.7

2929

13346

SPAT1238

SPAT

Brief therapy

2.4

122.0

912

2787

A97

ICPC

No disease

1.4

121.1

7456

41132

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

120.8

3250

15246

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

120.8

3309

15589

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

120.3

7883

43919

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

120.2

12581

74928

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

120.2

2560

11323

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.6

120.1

736

2042

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

120.1

2719

12222

R06AX13

ATC

loratadine; oral

1.4

120.0

6715

36463

J01FA09

ATC

clarithromycin; systemic

1.3

119.2

13756

82938

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

118.9

840

2500

EMB10

NOMESCO Finland

Tonsillectomy

1.6

118.9

2779

12592

R35

ICD-10 Finland

Polyuria

1.7

118.7

2340

10134

X15

ICPC

Vaginal symptom/complaint other

1.9

118.3

1765

7036

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

5.8

118.1

247

314

N92.5

ICD-10 Finland

Other specified irregular menstruation

2.0

118.0

1495

5644

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

117.5

10617

61969

N05AB03

ATC

perphenazine; systemic, rectal

2.0

117.1

1412

5239

R03BA01

ATC

beclometasone; inhalant

1.4

116.4

5588

29533

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.1

116.0

272

387

D12

ICPC

Constipation

2.0

115.5

1326

4833

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

115.3

2095

8865

Z10.0

ICD-10 Finland

Occupational health examination

1.5

115.1

4018

19964

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.6

114.8

743

2119

D07AC01

ATC

betamethasone; topical

1.3

114.8

15213

93193

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.3

114.4

926

2933

X58

ICD-10 Finland

Exposure to other specified factors

1.4

113.5

6110

32936

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

113.3

2862

13217

Z63.4

ICD-10 Finland

Disappearance and death of family member

3.0

113.2

554

1359

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.0

113.2

1283

4655

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

113.0

3316

15862

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

112.7

5982

32163

Z3232

NOMESCO Finland

Midwife

1.6

112.7

3362

16142

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

112.6

12536

75134

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

112.5

11351

67176

R01AD01

ATC

beclometasone; nasal

1.4

112.2

6275

34038

A02BA02

ATC

ranitidine; systemic

1.4

112.0

6900

38024

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

111.9

4731

24412

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

111.6

3574

17431

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.4

110.6

5745

30768

M01AH01

ATC

celecoxib; oral

1.4

110.6

6852

37786

R50.9

ICD-10 Finland

Fever, unspecified

1.4

110.5

5982

32266

D02

ICPC

Abdominal pain epigastric

1.6

110.4

2564

11593

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

110.3

4221

21359

Z3226

NOMESCO Finland

Physiotherapist

1.4

109.1

7051

39137

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

3.5

109.0

407

841

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

108.9

3205

15337

H01.0

ICD-10 Finland

Blepharitis

1.6

108.9

2805

13013

X14

ICPC

Vaginal discharge

2.1

108.8

1094

3793

M75.8

ICD-10 Finland

Other shoulder lesions

1.9

108.6

1594

6321

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

108.4

6174

33575

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.1

108.4

507

1211

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

108.3

4785

24888

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.6

107.1

676

1904

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

106.8

1708

6956

F60.5

ICD-10 Finland

Anankastic personality disorder

2.9

106.8

560

1429

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

106.8

1111

3903

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

106.6

3095

14764

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.7

106.0

272

420

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

105.9

8488

48625

N94.4

ICD-10 Finland

Primary dysmenorrhoea

2.2

105.8

925

3029

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

105.8

1795

7443

R52.0

ICD-10 Finland

Acute pain

1.9

105.7

1400

5365

A99

ICPC

Disease/condition unspecnature/site

1.5

105.6

3561

17552

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

105.4

14319

87765

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

105.4

4128

20978

W78

ICPC

Pregnancy

1.4

105.0

6187

33818

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

2.1

104.7

1053

3651

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.6

104.5

640

1775

E61.1

ICD-10 Finland

Iron deficiency

2.1

104.4

1110

3931

OAA64, ,

SPAT

1.7

104.2

2295

10234

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

103.4

12428

75040

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

102.7

1739

7206

F43.02

ICD-10 Finland

Acute stress reaction severe

4.4

102.7

289

483

H10

ICD-10 Finland

Conjunctivitis

1.5

102.6

3196

15482

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.5

102.5

389

813

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

102.5

15797

98153

H57.1

ICD-10 Finland

Ocular pain

1.8

102.3

1605

6498

U07

ICPC

Urine symptom/complaint other

1.6

102.3

2733

12785

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.6

102.2

2814

13257

Z00.8

ICD-10 Finland

Other general examinations

1.5

102.1

3262

15890

L11

ICPC

Wrist symptom/complaint

1.5

102.0

3805

19143

G44.8

ICD-10 Finland

Other specified headache syndromes

2.5

101.7

707

2089

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

101.5

5041

26759

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

101.3

2735

12824

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

101.2

3742

18793

R03AC03

ATC

terbutaline; inhalant

1.4

100.9

5709

30986

XQ800

NOMESCO Finland

Prick test

1.5

100.7

3181

15457

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

100.5

17164

107788

IHZ04, ,

SPAT

2.7

100.4

573

1532

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

2.1

100.0

1041

3657

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.8

99.8

1787

7526

R4110

NOMESCO Finland

Physiotherapy

1.3

99.6

10881

64884

J04.0

ICD-10 Finland

Acute laryngitis

1.8

99.5

1561

6320

P19

ICPC

Drug abuse

2.9

99.3

505

1267

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

99.1

3749

18909

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.6

98.8

2444

11219

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.3

98.8

410

909

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.3

97.9

842

2738

N05AB01

ATC

dixyrazine; systemic

3.0

97.7

475

1161

Z39.2

ICD-10 Finland

Routine postpartum follow-up

1.4

97.7

5302

28568

IGY02, ,

SPAT

2.7

97.5

587

1614

K04

ICPC

Palpitations/awareness of heart

1.7

97.5

2066

9117

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.5

97.4

684

2031

Z29

ICPC

Social problem NOS

2.2

97.2

911

3070

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

2.1

97.2

1064

3810

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

97.2

15323

95308

K05.22

ICD-10 Finland

Acute pericoronitis

1.7

97.1

2172

9720

M54.3

ICD-10 Finland

Sciatica

1.6

96.4

2287

10389

L13

ICPC

Hip symptom/complaint

1.3

96.2

6696

37521

R06.5

ICD-10 Finland

Mouth breathing

1.5

96.1

3437

17136

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.6

96.0

2688

12709

H93.1

ICD-10 Finland

Tinnitus

1.6

95.9

2646

12466

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

95.6

11989

72632

Z56.6

ICD-10 Finland

Other physical and mental strain related to work

3.4

95.5

375

802

L20.0

ICD-10 Finland

Besnier prurigo

1.5

95.5

3250

16039

R01AD59

ATC

mometasone, combinations; nasal

1.7

94.9

1777

7580

K03.80

ICD-10 Finland

Irradiated enamel

1.6

94.8

2262

10291

D07AA02

ATC

hydrocortisone; topical

1.4

94.0

5899

32524

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

94.0

8050

46453

F43.28

ICD-10 Finland

Adaptive disorder with other predominant symptoms

3.9

93.9

306

574

J02

ICD-10 Finland

Acute pharyngitis

1.7

93.5

1729

7349

T82

ICPC

Obesity

1.7

93.3

1722

7314

A23

ICPC

Risk factor NOS

1.5

93.2

3724

18976

NA3BG, ,

SPAT

1.8

93.0

1638

6865

J01AA04

ATC

lymecycline; systemic

1.4

92.9

5729

31498

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

92.4

1790

7707

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.4

92.2

5569

30515

SPAT1389

SPAT

Visit based on need for special support

2.0

92.2

1067

3900

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

91.9

1975

8747

R29

ICPC

Respiratory symptom/complaint other

1.6

91.7

2668

12721

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.5

91.3

3092

15237

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

91.0

2420

11301

SGC10

NOMESCO Finland

Pulp capping

1.4

90.8

3947

20434

SPAT1193

SPAT

Pap smear

1.4

90.8

4169

21802

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

90.4

10732

64520

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.9

90.4

1150

4347

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

90.2

10076

60132

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.0

89.7

436

1066

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.4

89.7

4913

26489

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

89.6

2191

10026

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.3

89.5

713

2243

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

89.3

3983

20716

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

89.2

8665

50804

C07AB07

ATC

bisoprolol; oral

1.2

88.6

17736

112809

NH3AA, ,

SPAT

1.6

88.3

2088

9475

P27

ICPC

Fear of mental disorder

2.5

87.8

590

1715

R06AX26

ATC

fexofenadine; oral

1.5

87.6

2842

13876

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

87.6

8949

52793

WX402

NOMESCO Finland

General anaesthesia

1.3

87.4

8649

50817

NA3AA, ,

SPAT

1.9

87.0

1254

4941

ZYC01, ,

SPAT

1.4

86.9

4074

21374

ZXD05

NOMESCO Finland

Urgent procedure

1.2

86.9

12421

76225

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

86.6

1748

7611

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

86.5

4059

21301

V03AA01, ,

ATC

2.5

86.4

578

1677

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

86.3

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

86.2

10317

62029

N62

ICD-10 Finland

Hypertrophy of breast

1.7

86.2

1659

7129

D10AX03

ATC

azelaic acid; topical

1.5

86.2

3307

16710

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

86.1

1301

5205

G43.8

ICD-10 Finland

Other migraine

2.3

85.6

698

2219

SPAT1254

SPAT

Administration of medicine

1.3

85.4

5684

31590

N64.4

ICD-10 Finland

Mastodynia

1.8

85.2

1344

5449

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

85.1

875

3060

G47.8

ICD-10 Finland

Other sleep disorders

2.3

84.9

714

2300

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.5

84.9

580

1700

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.9

84.8

437

1105

R03BA08

ATC

ciclesonide; inhalant

1.5

84.7

3445

17602

N63

ICD-10 Finland

Unspecified lump in breast

1.5

84.6

2679

13009

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.9

84.2

1173

4570

K05.32

ICD-10 Finland

Periodontitis NOS

1.5

84.2

3419

17466

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

84.0

2291

10759

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

83.9

929

3341

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.0

83.8

949

3442

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

18.7

83.7

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

83.5

4516

24281

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

83.1

3195

16147

JN1AE, ,

SPAT

1.8

82.8

1414

5871

SPAT1265

SPAT

Breathalyser

2.9

82.7

434

1109

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

82.5

1601

6894

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

82.3

2294

10826

J06.89

ICD-10 Finland

Other acute upper respiratory infections of multiple sites

2.0

82.1

946

3452

J01MA02

ATC

ciprofloxacin; systemic

1.2

81.9

15227

95934

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.9

81.9

413

1032

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

81.8

1363

5619

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

2.1

81.7

854

3006

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

81.6

1883

8491

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

81.5

2019

9264

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

81.5

2242

10547

N05CD08

ATC

midazolam; nasal, systemic

2.2

81.5

745

2486

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

81.4

1076

4120

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

3.7

80.9

285

566

Z72.1

ICD-10 Finland

Alcohol use

2.6

80.6

521

1486

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

80.5

3784

19852

S22.3

ICD-10 Finland

Fracture of rib

1.5

80.2

2457

11842

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

80.2

3902

20596

UJF32

NOMESCO Finland

Coloscopy

1.3

80.1

9699

58322

ZY000

NOMESCO Finland

Hospital inpatient

2.4

80.0

589

1788

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

1.6

80.0

2315

11017

L04

ICPC

Chest symptom/complaint

1.5

80.0

2397

11497

E03

ICD-10 Finland

Other hypothyroidism

1.6

79.9

2312

11003

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.1

79.7

832

2926

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

79.6

6601

37835

S02

ICPC

Pruritus

1.7

79.6

1453

6150

Z30.2

ICD-10 Finland

Sterilization

1.4

79.5

4135

22076

C05AA08

ATC

fluocortolone; rectal, topical

1.4

79.2

5074

28013

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

79.2

1765

7886

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

79.2

4483

24272

W79

ICPC

Unwanted pregnancy

2.3

79.2

682

2220

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

79.2

1915

8736

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.6

79.1

517

1483

F29

ICPC

Eye symptom/complaint other

1.4

79.1

3722

19529

Z72.2

ICD-10 Finland

Drug use

3.4

79.0

306

649

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

79.0

12180

75215

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

6.0

78.9

157

190

L29

ICD-10 Finland

Pruritus

2.3

78.8

647

2063

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

78.7

3116

15832

A06AC51

ATC

ispaghula, combinations; oral

1.6

78.7

1786

8018

L10

ICPC

Elbow symptom/complaint

1.6

78.5

2086

9733

J01FF01

ATC

clindamycin; systemic

1.2

78.4

10977

67072

EB1VA, ,

NOMESCO Finland

1.4

78.4

5096

28196

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

78.2

9824

59299

WX290, ,

SPAT

1.7

78.2

1531

6610

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.9

78.1

1009

3833

K80

ICPC

Cardiac arrhythmia NOS

1.5

78.1

2869

14364

X02

ICPC

Menstrual pain

1.9

78.1

1092

4261

130

Kela drug reimbursment

Malignant tumour

0.6

77.8

1137

14503

SPAT1336

SPAT

Request for examination

1.8

77.8

1318

5460

L28

ICPC

Limited function/disability (L)

1.3

77.7

5933

33611

N06AA10

ATC

nortriptyline; systemic

2.1

77.6

822

2907

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

77.6

3725

19609

L18

ICPC

Muscle pain

1.7

77.5

1616

7097

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.7

77.4

1547

6715

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

77.3

10489

63855

EB1SA, ,

SPAT

1.6

77.2

2260

10781

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

5.0

77.2

186

272

IAA01, ,

SPAT

3.0

77.1

366

883

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

77.0

3983

21239

J03

ICD-10 Finland

Acute tonsillitis

1.8

76.9

1197

4832

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.8

76.8

420

1098

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

76.7

1868

8535

R25.2

ICD-10 Finland

Cramp and spasm

2.0

76.7

934

3477

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.7

76.5

1432

6104

NG1AA, ,

SPAT

1.5

76.3

2722

13545

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

76.2

1737

7806

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.4

76.1

4687

25712

L05

ICPC

Flank/axilla symptom/complaint

1.6

76.0

2221

10591

D06BB04

ATC

podophyllotoxin; topical

1.6

75.8

2189

10411

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

75.7

1649

7324

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

2.0

75.6

917

3409

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.4

75.5

4623

25333

N06AA04

ATC

clomipramine; systemic

2.3

75.3

644

2090

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

75.3

1356

5717

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.6

75.3

476

1343

TLC02

NOMESCO Finland

Simple extraction of IUD

1.7

74.8

1656

7385

A06AD11

ATC

lactulose; oral

1.4

74.7

4593

25186

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

74.7

3766

19991

WZC00, ,

SPAT

1.4

74.4

4086

22000

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

1.7

74.3

1595

7056

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

74.0

2609

12952

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.7

73.8

1517

6636

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

73.3

17766

114476

L09

ICPC

Arm symptom/complaint

1.6

72.8

1856

8575

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.5

72.5

487

1416

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

72.4

1107

4445

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

72.4

2747

13838

IGY99, ,

SPAT

2.1

72.3

754

2651

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

3.3

72.2

292

638

WZA00

NOMESCO Finland

Concise certificate

1.5

72.1

2611

13028

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

71.9

5572

31603

N97.9

ICD-10 Finland

Female infertility, unspecified

1.6

71.9

2036

9639

M02AA07

ATC

piroxicam; topical

1.2

71.8

13646

85903

L86

ICPC

Back syndrome with radiating pain

1.5

71.6

2232

10794

SFA00

NOMESCO Finland

Small restoration

1.3

71.5

5530

31357

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

71.5

2343

11454

Z30.8

ICD-10 Finland

Other contraceptive management

1.8

71.3

1139

4635

ZYC02, ,

SPAT

1.7

71.2

1326

5645

K04.09

ICD-10 Finland

Pulpit UNS

1.6

71.1

1879

8754

WX002

NOMESCO Finland

Sedation and analgesia

1.3

71.0

6997

40967

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.2

70.8

303

686

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.0

70.5

335

809

N06AX17

ATC

milnacipran; oral

2.6

70.3

446

1261

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.4

70.2

3040

15702

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

70.1

1447

6336

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.6

70.0

430

1196

H60

ICD-10 Finland

Otitis externa

1.5

69.9

2082

9969

H29

ICPC

Ear symptom/complaint other

1.4

69.7

4165

22722

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

69.4

16416

105393

G04BD12

ATC

mirabegron; oral

1.4

69.1

3748

20130

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.4

69.0

3173

16565

M54.1

ICD-10 Finland

Radiculopathy

1.7

68.9

1456

6416

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021960) Folate [Moles/volume] in Serum or Plasma

12102

62336

1.54

323.01

1.5

20.86

20.40

nmol/l

2.33

10687

53751

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18096

101825

1.45

309.48

3.1

3.2

31.32

32.91

u/l

2.44

17164

96694

(1001926) Buprenorphine [Presence] in Urine by Screen method

3795

12044

2.40

307.65

2.8

2.2

—

(3028300) Cannabinoids [Presence] in Urine

4610

15912

2.22

307.65

2.6

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

38261

226977

1.83

307.65

3.9

3.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

13981

71803

1.57

307.65

2.1

1.9

—

(3015736) pH of Urine

21418

123220

1.45

307.65

3.2

5.93

5.88

1.56

2145

10397

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

45605

297366

1.87

307.65

4.3

4.1

5.74

5.84

mmol/l

61.11

42666

274426

(3007461) Platelets [#/volume] in Blood

51944

358213

5.12

307.65

20.1

18.5

260.74

255.23

e9/l

73.54

51137

349414

(3044889) 12 lead EKG panel

33681

206505

1.52

307.65

3.5

3.4

—

(3011288) Drugs identified in Urine by Screen method

3474

10311

2.56

307.65

3.5

3.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

50028

334936

2.76

307.65

14.5

14.4

72.36

74.81

umol/l

79.50

50012

334799

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

50224

337288

2.83

307.65

10.0

9.7

26.60

26.66

u/l

0.21

49037

326343

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

43113

277806

1.72

307.65

5.0

5.2

37.95

39.17

mmol/mol

160.07

40727

259119

(3028707) Methadone [Presence] in Urine by Screen method

2502

6156

3.06

307.65

3.3

2.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

9970

40862

1.96

307.65

2.0

1.7

1.44

1.41

4.60

8971

36421

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11529

48167

1.95

307.65

2.5

2.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

48604

317109

2.51

307.65

13.5

12.7

19.43

22.61

mg/l

89.18

39114

247192

(3035941) MCH [Entitic mass]

51970

358539

5.25

307.65

20.0

18.4

30.24

30.19

12.07

51598

353973

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

42552

242737

2.44

307.65

4.5

4.0

14.47

14.69

pmol/l

67.36

39876

222092

(3019198) Lymphocytes [#/volume] in Blood

26745

159080

1.46

307.65

5.3

6.0

2.00

1.94

e9/l

5.58

23838

142144

(3015377) Calcium [Moles/volume] in Serum or Plasma

17521

96194

1.49

307.65

2.7

3.4

2.35

mmol/l

3.16

15669

85246

(3037467) Urinalysis macro (dipstick) panel - Urine

34458

212750

1.52

307.65

4.3

4.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13889

67248

1.68

307.65

1.8

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14785

72678

1.67

307.65

1.3

1.25

1.73

u/ml

6.47

4323

19839

(3013115) Eosinophils [#/volume] in Blood

26802

159346

1.46

307.65

5.5

6.3

0.19

e9/l

1.26

23674

141129

(1002224) Polysomnography panel

3690

12986

2.15

307.65

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

48291

316949

2.32

307.65

14.4

14.3

3.93

3.95

mmol/l

43.54

47308

308086

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

46683

313642

1.74

307.65

4.6

4.4

2.83

mmol/l

0.30

44088

292671

(3009542) Hematocrit [Volume Fraction] of Blood

51926

357847

5.07

307.65

20.1

18.6

40.69

40.61

0.36

50034

336893

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

22329

125226

1.52

307.65

2.3

4063.32

76.18

nmol/l

0.50

20561

114013

(3007164) IgA [Mass/volume] in Serum or Plasma

12564

62576

1.61

307.65

1.4

2.24

2.34

g/l

9.00

7758

38965

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

45430

293738

1.92

307.65

11.7

88.61

85.30

ml/min/173m2

193.59

38039

240430

(3035350) Ketones [Presence] in Urine by Test strip

25733

151992

1.46

307.65

3.5

0.00

estimate

0.66

5517

30095

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

47286

288626

2.89

307.65

5.5

4.6

1.88

2.10

mu/l

2.13

44900

267326

(3027944) Amphetamines [Presence] in Urine

4515

15610

2.21

307.65

2.5

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

25916

153608

1.45

307.65

3.5

0.00

estimate

0.19

5322

28033

(3031040) Bacteria [#/volume] in Urine by Automated count

33288

200950

1.56

307.65

4.6

4.2

1146.57

1517.83

e6/l

0.59

424

2629

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

36265

217081

1.70

307.65

3.3

2.9

42.36

44.87

u/l

6.04

34447

204501

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10568

43503

1.96

307.65

2.4

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

51982

358757

5.29

307.65

20.2

18.6

136.03

136.00

g/l

0.21

51615

354227

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7019

27624

1.98

307.65

2.3

1.9

—

(3006315) Basophils [#/volume] in Blood

25970

154112

1.45

307.65

5.3

6.1

0.04

e9/l

0.10

22642

134638

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5784

21875

2.04

307.65

2.1

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

27531

138016

1.95

307.65

3.1

2.8

91.87

114.72

ug/l

49.31

26026

128801

(3001019) Free T4 and TSH panel - Serum or Plasma

4653

18201

1.95

307.65

1.7

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

42421

277755

1.58

307.65

15.6

15.1

14.81

14.90

0.17

41855

272814

(40760892) CBC W Ordered Manual Differential panel - Blood

24647

145177

1.44

307.65

5.6

6.5

—

(3016879) Cocaine [Presence] in Urine

4348

14601

2.27

307.65

2.6

2.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

48162

315957

2.29

307.65

14.3

14.1

139.53

139.66

mmol/l

27.65

47241

307797

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

20494

114267

1.50

307.65

2.0

1.9

98.39

96.97

pmol/l

3.85

10735

59847

(3013707) Erythrocyte sedimentation rate by Westergren method

38247

226666

1.84

307.65

4.0

3.9

9.83

11.36

mm/h

114.11

35877

210813

(3013650) Neutrophils [#/volume] in Blood by Automated count

29211

177817

1.44

307.65

7.3

9.2

4.04

4.06

e9/l

0.62

25561

156148

(3021601) Nitrite [Presence] in Urine by Test strip

25747

152065

1.46

307.65

4.7

0.00

estimate

0.04

5430

28757

(3048689) Calprotectin [Mass/mass] in Stool

8836

40270

1.72

307.65

2.2

2.5

100.32

136.24

ug/g

23.47

6961

31917

(3024731) MCV [Entitic volume]

51971

358577

5.25

307.65

20.0

18.5

90.60

90.53

3.38

51596

354004

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

25704

152614

1.44

307.65

4.9

6.1

10.41

11.08

umol/l

15.68

24210

144512

(3026361) Erythrocytes [#/volume] in Blood

51973

358619

5.25

307.65

20.1

18.5

4.52

4.53

e12/l

2.11

51068

348930

(3010813) Leukocytes [#/volume] in Blood

51977

358662

5.27

307.65

20.1

18.5

6.71

6.68

e9/l

2.65

51078

348900

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

37723

231171

1.66

307.65

6.6

7.4

73.40

76.96

u/l

62.56

35740

218314

(3023323) Follitropin [Units/volume] in Serum or Plasma

4583

16718

2.09

307.65

1.4

1.3

25.32

27.04

iu/l

2.78

3961

14411

(40761511) CBC panel - Blood by Automated count

49881

332704

2.74

307.65

12.4

11.8

—

(3001604) Monocytes [#/volume] in Blood

25920

153791

1.45

307.65

5.3

6.0

0.56

0.57

e9/l

15.77

22627

134510

(3027008) Opiates [Presence] in Urine

4594

15877

2.21

307.65

2.5

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

4580

15757

2.22

307.65

2.6

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

45766

307019

1.65

307.02

4.1

4.0

1.46

1.47

mmol/l

2.83

43215

286979

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

16784

93255

1.46

305.92

2.6

58.11

61.75

u/l

1.50

15466

86253

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

46017

309210

1.66

305.50

4.2

4.1

4.72

4.73

mmol/l

1.61

43561

290105

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

13391

71329

1.49

301.28

2.2

2.71

2.90

mg/l

17.84

11476

61240

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10619

54112

1.54

293.29

1.3

28.99

34.20

iu/ml

0.65

3206

17500

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

12632

67008

1.49

287.56

1.7

1.8

0.86

1.16

mg/l

33.57

9244

50592

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

7848

37507

1.62

284.79

1.5

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4055

16096

1.90

281.52

2.4

2.3

6289.41

6093.30

u/l

0.13

1492

6531

(3002030) Lymphocytes/100 leukocytes in Blood

24959

150563

1.39

278.44

5.4

6.2

29.34

28.51

30.25

23539

141986

(3018010) Neutrophils/100 leukocytes in Blood

24623

148331

1.39

275.99

5.3

6.0

56.26

56.90

16.12

23210

139753

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10018

50985

1.53

275.93

1.3

7.55

11.87

u/ml

9.13

4118

20076

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

44238

296195

1.55

270.91

3.7

1.30

1.29

mmol/l

3.00

41487

275218

(3006504) Eosinophils/100 leukocytes in Blood

24047

144764

1.39

267.26

5.4

6.2

2.85

2.83

0.46

22557

135905

(3019069) Monocytes/100 leukocytes in Blood

24167

145608

1.39

267.23

5.7

6.5

8.22

8.44

22.29

22722

136945

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

11051

58144

1.49

257.10

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

23501

141505

1.38

257.05

5.4

6.6

1.22

mmol/l

1.50

20027

120315

(3023511) Choriogonadotropin [Units/volume] in Urine

2349

7886

2.22

255.07

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

22763

136603

1.38

252.50

8.5

9.2

0.00

e9/l

4.71

18613

112580

(3013826) Glucose [Moles/volume] in Serum or Plasma

27910

173233

1.37

249.64

4.4

4.6

6.39

6.64

mmol/l

74.50

26044

160239

(3022096) Basophils/100 leukocytes in Blood

23198

140039

1.37

245.48

5.4

6.2

0.69

0.68

1.53

21644

131024

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

21338

127822

1.36

232.59

5.1

6.0

1.21

mmol/l

1.44

19669

116940

(3024561) Albumin [Mass/volume] in Serum or Plasma

20749

124215

1.36

224.39

4.0

4.9

36.61

35.89

g/l

67.61

19278

115584

(3018095) Leukocytes [#/volume] in Urine

17750

103704

1.37

223.91

3.6

3.5

73.86

89.92

e6/l

1.79

12192

71401

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5865

27554

1.62

223.54

2.0

2.2

374.63

376.14

nmol/l

0.23

5365

25444

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

19814

118326

1.35

214.66

3.6

—

(3003338) MCHC [Mass/volume]

41670

279078

1.42

210.59

17.1

15.9

333.09

332.75

g/l

12.28

41429

276998

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17881

105357

1.36

210.04

3.4

3.3

71.14

55.38

ng/l

0.29

9671

65953

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9466

50082

1.46

207.69

2.5

3.0

2.43

2.45

mmol/l

41.46

8227

43853

(3019832) Treponema pallidum Ab [Presence] in Serum

8069

41544

1.49

202.59

1.8

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2718

10511

1.93

201.73

1.9

1.8

—

(3018418) pH of Serum or Plasma

14608

83885

1.37

199.50

3.4

4.1

7.40

0.81

2784

15961

(3021387) Prolactin [Units/volume] in Serum or Plasma

3256

13441

1.81

197.33

1.6

314.77

311.58

mu/l

0.14

2883

12140

(36304419) Bacteria [Presence] in Urine

13698

77990

1.38

196.64

3.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

8032

41640

1.48

193.93

1.7

1.6

—

(40768797) Stomach Pathology biopsy report

7748

39931

1.48

192.53

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

14120

81071

1.37

191.25

3.9

0.00

estimate

0.00

5331

27801

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14688

84935

1.36

189.83

2.2

2.1

210.97

205.22

u/l

0.21

13871

79791

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3931

17403

1.70

186.60

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

12361

69968

1.37

181.03

3.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10646

58903

1.40

178.49

1.6

35074905.85

37413909.46

pmol/l

0.14

9132

49263

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10760

59701

1.39

177.24

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

782

1819

3.16

174.45

2.0

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

8190

43575

1.44

170.26

1.4

512.82

552.77

titre

0.99

1466

8849

(36660697) Celiac disease serology panel - Serum

5307

25863

1.55

169.87

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

14779

86880

1.33

166.17

3.1

72.10

81.02

e6/l

0.31

11095

65936

(40768804) Tissue Pathology biopsy report

20277

124560

1.30

166.13

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

14463

84782

1.33

165.70

3.0

3.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4861

23378

1.57

164.64

1.2

123.33

147.84

iu/ml

4.61

1908

8870

(3030467) Casts [#/volume] in Urine by Automated count

13638

79456

1.34

162.18

3.0

0.31

0.41

e6/l

8.55

10138

59759

(40758558) Short blood count panel - Blood

13119

76146

1.34

159.47

5.6

7.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5498

27406

1.51

157.89

2.6

2.5

35.12

45.81

u/l

2.36

4721

23496

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1683

5981

2.08

157.30

1.4

—

(3019150) Specific gravity of Urine by Refractometry

11577

66324

1.35

152.24

3.9

3.8

1.02

kg/l

0.47

1494

10179

(3036180) Methadone [Presence] in Urine

697

1654

3.10

150.48

3.0

2.2

—

(3025941) Bacteria identified in Stool by Culture

3938

18484

1.60

147.12

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4232

20225

1.57

146.40

3.2

3.4

4.52

pmol/l

0.06

3774

18108

(3019309) Folate [Moles/volume] in Red Blood Cells

8812

48951

1.37

139.34

1.7

1214.01

1161.43

nmol/l

5.81

6769

37298

(3003327) Ova and parasites identified in Stool by Light microscopy

2559

11016

1.73

133.00

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

12720

75054

1.31

132.91

3.7

3.9

93.72

92.30

8.73

12319

73131

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4361

21472

1.52

131.24

2.5

2.2

12.51

12.38

nmol/l

0.48

3940

19570

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1408

5026

2.07

129.85

1.6

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4180

20476

1.53

128.68

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

4197

20623

1.52

127.30

1.3

234.23

237.13

u/ml

0.04

3872

19082

(3020961) Endomysium IgA Ab [Titer] in Serum

3342

15679

1.59

124.28

1.1

116.83

215.76

titre

1.63

425

(3000850) Epithelial cells [#/volume] in Urine

10375

59978

1.32

124.08

2.4

2.6

6.95

6.12

e6/l

4.30

9227

53661

(3009214) Lutropin [Units/volume] in Serum or Plasma

2411

10419

1.72

123.39

1.4

8.90

9.92

u/l

3.70

1965

8600

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6251

33711

1.40

116.01

2.3

2.8

6.68

8.17

umol/l

7.73

5193

29175

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

8518

48491

1.33

111.75

2.7

1.07

1.18

e6/l

0.91

4512

27160

(3000492) Spirometry study

5934

31915

1.40

111.54

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

7953

44833

1.34

111.45

2.2

2.5

14.30

13.86

umol/l

0.46

7452

41844

(3004716) Salmonella sp identified in Stool by Organism specific culture

3641

17839

1.52

111.29

1.4

—

(3026008) Bacteria identified in Urine by Culture

14620

89398

1.26

111.16

3.0

2.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2631

12001

1.63

109.42

1.3

226.63

223.69

miu/ml

0.15

1236

5673

(3022145) Colonoscopy Study observation

6129

33343

1.38

107.29

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7947

45190

1.33

104.21

2.8

3.75

3.31

e6/l

2.06

3967

24017

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9193

53499

1.30

101.88

3.7

3.5

238.04

494.11

ng/l

9.32

6061

38558

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2120

9339

1.68

100.74

1.9

1.7

39.69

40.34

nmol/l

0.51

2081

9140

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1567

6335

1.83

100.33

2.0

1.8

194.99

195.99

pmol/l

0.13

1484

6061

(3008898) HLA-B27 [Presence]

2543

11810

1.60

98.02

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2025

8878

1.69

97.92

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2045

8991

1.68

97.85

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2040

8966

1.68

97.73

1.2

—

(1761868) Lipid panel - Serum or Plasma

18660

118546

1.23

96.82

2.5

2.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7260

41146

1.33

96.64

2.2

2.5

2.44

2.37

g/l

20.49

6705

38048

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1372

5399

1.87

95.61

1.4

1.3

22.92

25.69

u/l

2.36

1121

4480

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2487

11612

1.59

93.64

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1145

4374

1.93

87.23

1.5

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

479

1281

2.74

83.97

2.2

2.1

178.13

127.64

umol/l

1.66

246

656

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2463

11785

1.55

83.17

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

22292

145578

1.20

82.55

2.4

2.5

—

(21494755) Public health laboratory ask at order entry panel

6662

38075

1.31

82.31

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

12386

76374

1.24

82.01

2.2

2.5

1906.67

4019.19

umol/l

15.22

11059

67722

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1350

5567

1.79

80.89

1.5

0.36

0.42

nmol/l

1.68

1085

4379

(3026782) Osmolality of Urine

9476

56908

1.26

78.94

2.6

2.8

527.44

538.82

mosm/kgh2o

4.53

8009

48906

(3024666) Lithium [Moles/volume] in Serum or Plasma

619

1951

2.33

77.43

11.6

12.1

0.60

0.62

mmol/l

2.46

584

1790

(3007853) Bacteria identified in Skin by Aerobe culture

6227

35541

1.31

77.27

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2553

12525

1.51

76.69

1.5

1.6

3.35

3.92

mg/l

3.39

1962

8851

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1607

7075

1.67

76.30

1.1

1.76

2.24

u/ml

1.40

771

3543

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4854

26765

1.35

76.24

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2418

11751

1.52

75.92

1.5

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2610

12941

1.49

74.45

1.1

23.92

6.85

u/ml

0.58

203

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1978

9233

1.58

74.28

1.4

1.3

—

(3042517) Benzodiazepines panel - Urine

216

373

4.23

73.86

3.1

3.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3678

19562

1.40

72.00

1.3

45.53

50.71

au/ml

0.64

165

958

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6595

38270

1.29

71.86

2.3

2.6

23.52

22.93

2.64

5736

32691

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1386

5966

1.71

71.50

1.1

1.88

2.01

u/ml

0.17

645

2962

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3966

21387

1.38

71.45

2.3

22.66

22.43

au/ml

0.05

358

1766

(3022217) INR in Platelet poor plasma by Coagulation assay

19806

129154

1.19

70.52

11.7

12.7

1.15

1.22

inr

16.56

6461

38495

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1227

5141

1.76

69.63

1.1

3.91

4.32

u/ml

0.34

548

2490

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7714

45857

1.26

68.90

2.8

3.5

0.82

mmol/l

0.76

7162

43058

(3009466) Valproate [Moles/volume] in Serum or Plasma

1068

4309

1.82

68.75

5.4

5.2

366.46

372.98

umol/l

0.72

940

3739

(3020191) Ethanol [Moles/volume] in Serum or Plasma

715

2523

2.08

67.98

1.7

1.5

1.55

1.38

promille

2.02

519

1964

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1157

4804

1.77

67.73

1.1

5.38

5.20

u/ml

0.10

465

2028

(3003888) Timothy IgE Ab [Units/volume] in Serum

1441

6366

1.67

67.49

1.1

5.56

5.82

u/ml

0.22

728

3295

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1812

8491

1.57

66.85

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2500

12576

1.47

66.20

1.2

0.63

0.91

u/ml

0.83

254

1048

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1746

8184

1.57

64.32

1.1

—

(40761536) Microorganisms panel - Urine sediment

4697

26468

1.32

62.97

3.7

3.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1360

6046

1.66

62.17

1.1

0.78

1.20

u/ml

2.58

525

2574

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1728

8151

1.56

61.91

1.4

303.79

275.14

ug/g

4.36

939

4669

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1954

9528

1.51

60.19

1.1

4.39

5.41

u/ml

0.43

277

1292

(3000494) Fungus identified in Specimen by Culture

5924

34848

1.27

56.76

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

985

4131

1.75

55.74

1.1

1.0

0.53

0.45

u/ml

0.17

230

1072

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5202

30213

1.28

55.17

1.7

—

(4200892) Spirometry reversibility

3776

21056

1.33

54.09

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1147

5061

1.67

53.97

1.1

11.96

11.90

au/ml

0.01

331

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

12226

77910

1.19

52.90

1.6

1.44

1.38

mmol/l

7.15

10677

66110

(3014111) Lactate [Moles/volume] in Serum or Plasma

4194

23830

1.31

52.48

6.2

7.2

1.37

1.34

mmol/l

0.89

4080

23261

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5151

30066

1.27

52.32

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

14723

95567

1.17

50.42

2.2

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6257

37556

1.24

49.79

1.7

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7312

44665

1.22

49.24

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1225

5647

1.59

48.41

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2173

11296

1.42

48.05

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1220

5649

1.59

47.33

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1014

4505

1.65

46.51

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2210

11613

1.40

45.92

1.2

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

13779

89549

1.16

45.33

3.1

3.2

7.89

7.88

mmol/l

0.01

12012

76467

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1083

4949

1.61

44.40

1.1

2.67

2.87

u/ml

0.23

542

2467

(3002256) Pathology report gross observation

6345

38709

1.22

42.71

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1535

7648

1.48

42.50

1.3

464.65

534.73

mg/l

3.85

1456

7287

(40761535) Cells panel - Urine sediment

3942

22856

1.28

41.79

3.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1372

6749

1.49

40.47

1.3

1.5

1141.01

2293.24

e6/l

0.79

1092

5500

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1369

6745

1.49

40.07

1.3

1.4

36.75

29.23

e6/l

0.28

1031

5227

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3598

20732

1.28

40.02

1.5

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1013

4690

1.58

39.37

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

511

1954

1.91

39.05

1.7

1.5

—

(3045414) Leukocytes [Presence] in Urine

2457

13483

1.34

38.92

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1355

6732

1.48

38.07

1.2

1.3

3.66

3.72

mmol/l

1.45

1272

6310

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2365

12958

1.34

37.84

3.9

4.4

24.15

24.14

mmol/l

0.04

2294

12691

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1513

7696

1.44

37.64

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1007

4744

1.56

36.33

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2382

13213

1.33

35.03

2.1

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3729

21924

1.26

34.97

1.4

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1272

6363

1.47

34.54

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1122

5475

1.50

34.45

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

466

1814

1.88

33.83

1.4

1.3

—

(44813793) Dust mix specific IgE antibody measurement

565

2342

1.77

33.49

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

535

2182

1.79

33.48

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1035

5008

1.52

33.10

2.4

2.5

13.07

13.14

1.57

1026

4941

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5632

34752

1.20

33.08

6.2

6.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11097

72345

1.15

32.87

2.1

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5866

36352

1.20

32.86

4.5

6.2

1.03

1.04

mmol/l

3.70

5449

34000

(3017732) Neutrophils [#/volume] in Blood

3672

21752

1.25

32.14

2.3

2.8

4.42

4.86

e9/l

1.91

3047

17879

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

522

2151

1.78

31.60

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2724

15611

1.29

31.45

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2537

14407

1.30

31.43

2.3

2.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2866

16551

1.28

31.13

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

961

4640

1.52

31.07

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

517

2140

1.77

30.84

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3879

23252

1.23

30.39

2.2

2.7

10.42

10.56

g/l

1.31

3500

21333

(4034850) Laboratory test

1739

9419

1.36

29.98

9.2

8.9

—

(3003694) ABO and Rh group [Type] in Blood

14121

93985

1.13

29.89

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1515

8036

1.38

29.76

1.9

3.83

20.54

iu/l

1.53

569

3020

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1118

5633

1.46

29.31

1.2

1.3

3.16

3.68

ug/l

2.12

1030

5070

(3023368) Bacteria identified in Blood by Culture

11327

74495

1.14

28.79

4.1

4.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3874

23353

1.22

28.70

2.5

72.99

68.07

ml/min/173m2

11.40

1618

8951

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3769

22674

1.23

28.47

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

608

7046

0.62

28.24

3.8

4.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1058

5316

1.46

28.15

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1811

9977

1.33

27.90

1.7

1.8

—

(3025130) Human papilloma virus identified in Specimen

1016

5075

1.47

27.87

1.7

—

(3042936) Bacteria identified in Isolate by Culture

6503

41216

1.17

27.59

1.9

2.0

—

(3000991) Gas panel - Venous blood

3775

22785

1.22

27.59

7.6

8.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

5370

33523

1.19

27.36

1.7

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6760

43009

1.17

27.29

1.9

2.2

29.54

29.67

1.12

6564

41721

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

152

406

2.73

27.12

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1071

5433

1.44

27.12

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

386

1528

1.85

26.73

1.8

1.6

1896197.22

1799858.61

iu/ml

0.06

112

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1273

6688

1.40

26.51

1.2

37.90

44.23

u/ml

0.58

113

673

(3028026) IgM [Mass/volume] in Serum or Plasma

3033

17962

1.24

26.49

1.6

1.9

1.32

1.31

g/l

0.09

2778

16441

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1126

5815

1.42

25.88

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1125

5813

1.42

25.78

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4342

26753

1.20

25.56

2.1

2.3

0.23

0.22

g/l

16.98

4037

24955

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1766

9835

1.32

25.24

1.7

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

1414

7625

1.36

25.11

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1615

8889

1.33

25.06

1.2

1.3

24.81

37.78

u/ml

1.34

537

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

563

2537

1.62

24.67

1.7

2.0

20.34

19.03

nmol/l

2.40

535

2407

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

700

3327

1.54

24.45

1.2

54.20

25.21

nmol/l

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

381

1557

1.79

23.87

1.4

1.2

265.67

331.97

u/l

0.74

352

1461

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

451

1940

1.70

23.64

1.3

5.26

5.33

umol/l

0.17

415

1797

(3034274) Bile acid [Moles/volume] in Serum --fasting

1036

5367

1.41

23.44

1.9

2.2

5.44

6.53

umol/l

1.57

764

3901

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3758

23036

1.20

23.32

3.2

3.8

1.23

mmol/l

0.83

3293

20118

(3023410) Appearance of Cerebral spinal fluid

650

3072

1.55

23.31

1.4

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

486

2143

1.66

23.22

1.0

3.18

2.14

u/ml

0.42

109

531

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1917

10923

1.29

23.13

1.5

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1757

9911

1.30

22.89

1.6

1.7

1.18

g/l

0.29

1676

9431

(3008402) Methanol [Moles/volume] in Serum or Plasma

116

294

2.88

22.86

1.1

1.3

—

0.96

mmol/l

—

(3007463) Buprenorphine [Presence] in Urine

134

3.92

22.70

9.4

7.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

4691

29404

1.18

22.55

2.2

2.6

1.78

1.77

0.28

4112

26136

(3015076) Soybean IgE Ab [Units/volume] in Serum

446

1949

1.67

22.09

1.0

0.54

0.63

u/ml

0.17

487

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1705

9628

1.30

22.05

1.7

1.8

0.23

g/l

0.20

1622

9129

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

493

2213

1.63

22.00

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

456

2012

1.66

21.78

1.1

7.22

8.36

iu/ml

0.42

123

529

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4537

28465

1.18

21.53

3.2

—

(3038515) Glucose [Moles/volume] in Venous blood

480

5494

0.63

21.21

3.1

3.2

6.92

7.49

mmol/l

4.55

465

5397

(3023183) Ammonium ion [Moles/volume] in Plasma

1062

5623

1.38

21.20

2.4

2.9

32.70

34.30

umol/l

1.36

952

5112

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

292

1144

1.86

21.03

2.3

2.4

134.15

155.58

nmol/l

3.35

264

978

(3007566) Smooth muscle Ab [Titer] in Serum

1577

8900

1.30

20.50

1.2

1.3

104.48

122.86

titre

0.51

145

824

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1465

8208

1.31

20.11

1.3

7.43

9.47

u/ml

0.67

228

1276

(3050129) First trimester maternal screen panel - Serum or Plasma

2458

14672

1.23

19.92

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1442

8083

1.31

19.73

1.3

4.73

7.14

u/ml

0.98

145

843

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1196

6533

1.34

19.61

1.3

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

675

3341

1.48

19.56

1.3

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

480

2210

1.59

19.38

1.0

1.1

4.30

1.53

u/ml

0.65

138

717

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

277

1102

1.84

19.07

1.3

1.4

14.07

14.92

pmol/l

1.87

236

928

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

295

1198

1.80

19.01

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

319

1329

1.75

18.86

1.4

72.76

73.17

0.18

303

1261

(3024928) Oxygen saturation in Venous blood

1051

5665

1.36

18.83

3.1

3.4

—

(3034770) Mitochondria Ab [Titer] in Serum

1538

8755

1.29

18.75

1.2

779.23

965.18

titre

0.52

249

(3013512) EKG study

11920

80281

1.11

18.52

3.5

3.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10834

72682

1.11

18.11

2.8

2.9

1067.54

1248.90

ng/l

4.46

8874

61428

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1223

6796

1.32

17.86

1.9

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

3275

20309

1.19

17.78

3.1

3.3

4.71

4.65

kpa

0.72

3129

19661

(3015183) Erythrocyte sedimentation rate

388

1735

1.63

17.71

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

306

1284

1.74

17.69

1.4

1.8

2.00

1.97

umol/l

0.33

280

1208

(3045683) HLA typing for celiac disease panel - Blood or Tissue

452

2099

1.57

17.66

1.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

811

4245

1.40

17.43

1.3

0.58

1.26

nmol/l

1.14

784

4085

(4062490) Immunoglobulin typing, IgG

639

3204

1.46

17.40

1.3

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

252

3210

0.57

17.35

2.4

2.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

637

3195

1.46

17.32

1.3

1.4

3.07

2.93

g/l

1.16

449

2214

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

308

1304

1.72

17.27

1.4

553.44

656.51

mu/l

0.47

292

1236

(3017509) Phencyclidine [Presence] in Urine

136

432

2.30

17.19

2.3

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3519

22021

1.18

17.14

2.4

2.2

5.76

7.41

ug/l

5.45

3021

19231

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1459

8351

1.28

17.07

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

635

3196

1.45

16.97

1.3

1.4

0.37

0.41

g/l

2.31

451

2218

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

605

3017

1.47

16.96

1.0

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

635

3201

1.45

16.83

1.3

1.4

6.46

6.79

g/l

1.61

448

2216

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3946

24961

1.16

16.76

3.6

4.0

5.87

5.83

kpa

2.04

3799

24242

(3024980) IgG subclass 4 [Mass/volume] in Serum

935

5048

1.36

16.64

1.5

1.6

0.72

0.74

g/l

0.17

712

3816

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.29

16.60

1.5

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

802

4232

1.39

16.46

1.3

0.22

nmol/l

0.02

240

(3020891) Body temperature

1788

10546

1.24

16.22

4.7

4.9

—

(3008037) Lactate [Moles/volume] in Venous blood

555

5835

0.69

16.18

2.9

3.0

1.54

mmol/l

0.01

535

5718

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

655

3355

1.43

15.97

1.1

94.50

66.96

au/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

234

941

1.81

15.68

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2732

16862

1.19

15.65

6.3

7.2

24.80

24.77

mmol/l

0.20

2708

16702

(3002032) Base excess in Venous blood by calculation

3914

24896

1.16

15.41

3.7

4.0

1.71

1.87

mmol/l

1.78

3327

21260

(3010421) pH of Blood

1310

7497

1.28

15.38

3.2

3.8

7.42

0.06

1194

6847

(3012544) pH of Venous blood

4044

25829

1.15

15.04

3.6

4.0

7.39

7.38

0.38

203

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

367

1696

1.58

14.74

1.1

4.52

5.09

nmol/l

0.08

317

(3035637) Corticotropin [Mass/volume] in Plasma

711

3749

1.39

14.72

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2706

16778

1.18

14.71

8.5

9.6

93.81

94.01

0.95

2693

16720

(3052851) Hemolysis interference index of Serum or Plasma

1499

8771

1.25

14.64

2.8

3.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

261

1109

1.72

14.55

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

723

3831

1.38

14.54

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

250

1051

1.74

14.47

2.0

2.3

1.02

1.10

ug/l

0.26

237

978

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

243

1018

1.74

14.25

1.1

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2690

16725

1.18

14.16

8.4

9.4

1.51

1.37

6.67

2682

16617

(3003181) Sodium [Moles/volume] in Urine

820

4460

1.34

13.99

1.4

61.88

63.48

mmol/l

0.49

647

3505

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2682

16711

1.18

13.76

8.5

9.5

0.68

0.16

2673

16617

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

183

713

1.87

13.62

1.3

1.2

123.21

134.68

nmol/l

0.26

137

528

(3045424) Erythrocytes [Presence] in Urine

930

5172

1.32

13.62

1.4

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2786

17456

1.17

13.35

2.3

3.3

33.50

51.98

u/ml

3.00

2696

16851

(3041806) Other cells [#/volume] in Blood by Manual count

362

1708

1.55

13.35

1.5

1.4

—

(3025159) Blasts/100 leukocytes in Blood

3610

23068

1.15

13.32

3.8

4.3

0.15

0.32

0.93

769

6126

(3049717) Cytology report of Urine Cyto stain

1494

8844

1.24

13.18

2.4

2.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

320

1475

1.58

13.07

1.5

1.6

18.96

5.12

nmol/l

0.40

269

1226

(43055514) Macroprolactin [Presence] in Serum or Plasma

233

990

1.72

13.05

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2259

13940

1.19

13.00

8.6

9.8

24.40

24.31

mmol/l

0.71

2172

13513

(3012501) Base excess in Blood by calculation

1131

6508

1.27

12.79

3.3

3.8

2.33

2.49

mmol/l

1.28

743

4347

(3013290) Carbon dioxide [Partial pressure] in Blood

1131

6510

1.27

12.76

3.3

3.8

4.99

5.01

kpa

0.24

1108

6352

(3027801) Oxygen [Partial pressure] in Arterial blood

4687

30565

1.13

12.67

6.7

7.5

12.40

12.73

kpa

3.95

4480

29165

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4689

30581

1.13

12.65

6.7

7.5

5.09

5.08

kpa

0.08

4484

29191

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2121

13049

1.19

12.64

2.0

39.92

39.54

u/l

0.40

1914

11732

(3002079) Sodium [Moles/time] in 24 hour Urine

310

1433

1.58

12.53

1.3

1.2

150.44

159.14

mmol/24h

1.15

310

1433

(3016244) Insulin [Units/volume] in Serum or Plasma

440

2193

1.47

12.53

2.9

3.3

27.60

28.34

mu/l

0.14

408

2057

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1322

7773

1.24

12.44

1.4

82.23

131.48

pmol/l

5.53

1279

7584

(3019420) Tryptase [Mass/volume] in Serum or Plasma

363

1745

1.52

12.34

1.4

1.5

6.17

8.47

ug/l

3.65

335

1575

(3027315) Oxygen [Partial pressure] in Blood

1133

6554

1.26

12.29

3.3

3.8

8.85

8.75

kpa

1.16

1110

6395

(3008295) Osmolality of Serum or Plasma

527

2730

1.41

12.20

1.6

1.5

279.61

279.94

mosm/kgh2o

0.12

389

2171

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

642

3439

1.36

12.16

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

636

3405

1.36

12.10

2.0

27.23

25.45

mg/l

0.32

186

900

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

147

555

1.93

12.09

1.7

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3613

23244

1.14

12.07

3.6

4.0

0.65

0.67

0.16

930

7288

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1589

9557

1.22

12.07

2.1

2.4

417.04

518.98

ug/l

0.94

1451

8885

(3018405) Lactate [Moles/volume] in Arterial blood

1536

9208

1.22

12.05

4.0

4.2

1.38

1.36

mmol/l

0.19

1518

9051

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

176

707

1.82

11.98

1.9

—

(1616796) Gas panel - Central venous blood

1094

6325

1.27

11.93

2.8

3.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

332

1578

1.54

11.91

1.3

1.5

25.73

24.97

umol/l

0.17

313

1500

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

127

458

2.02

11.89

1.1

1.0

85.86

80.10

ug/l

0.80

107

377

(3006922) Hepatitis E virus Ab [Presence] in Serum

456

2313

1.44

11.88

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1256

7384

1.24

11.85

1.9

2.3

0.04

0.02

g/l

0.28

1135

6769

(3005082) Progesterone [Moles/volume] in Serum or Plasma

440

2221

1.45

11.77

1.3

1.4

31.25

31.51

nmol/l

0.07

398

2050

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

501

2591

1.41

11.73

1.1

—

(3003396) Base excess in Arterial blood by calculation

4673

30605

1.12

11.73

6.8

7.5

0.94

1.04

mmol/l

0.92

3756

24350

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

493

2546

1.41

11.64

1.5

1.3

181.83

187.63

pmol/l

0.10

493

2546

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

461

2354

1.43

11.60

1.2

1.3

2.65

1.60

u/ml

0.83

238

1316

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1119

6510

1.26

11.59

1.2

8.96

15.92

u/ml

0.34

101

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

529

2768

1.40

11.59

1.2

35.72

43.54

mg/l

2.58

430

2323

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

762

4233

1.32

11.35

1.9

1.8

3401.14

3814.49

titre

0.09

185

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1163

6815

1.25

11.32

1.9

2.3

0.00

g/l

0.29

1048

6215

(3023520) Reticulocytes [#/volume] in Blood

3356

21583

1.14

11.27

2.2

2.7

71.63

70.47

e9/l

0.96

2408

16260

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1126

6578

1.25

11.26

1.2

1.3

250.26

263.11

u/ml

0.90

716

4307

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1148

6726

1.25

11.20

1.9

2.3

0.00

g/l

-0.00

1046

6197

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1132

6630

1.25

11.08

1.2

5.09

5.58

u/ml

0.07

510

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

420

2127

1.44

11.07

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

418

2118

1.44

10.99

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1187

7002

1.24

10.90

1.2

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1991

12347

1.18

10.87

1.4

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

3734

24239

1.13

10.85

3.8

4.3

0.14

0.11

0.67

885

7220

(3022621) pH of Urine by Test strip

3062

19623

1.14

10.84

2.7

2.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

333

1619

1.50

10.81

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

511

2694

1.39

10.75

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1276

7599

1.23

10.73

1.8

2.2

38.73

37.92

g/l

5.05

1107

6637

(3019225) pH of Specimen

4211

27561

1.12

10.68

3.5

4.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

424

2167

1.43

10.66

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

945

5448

1.27

10.61

2.3

3.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

535

2849

1.37

10.59

1.4

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

3902

25447

1.13

10.51

3.7

4.2

0.97

0.93

0.31

1050

8395

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

507

2682

1.38

10.47

1.1

235.52

263.36

mg/l

1.34

439

2359

(3028717) Thiamine [Mass/volume] in Blood

285

2.23

10.45

1.2

—

(3016502) Oxygen saturation in Arterial blood

4159

27242

1.12

10.40

7.1

7.9

95.81

95.84

0.10

4033

26175

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9326

72514

0.92

10.38

4.4

4.3

2.20

2.78

ug/l

1.90

8490

65724

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

428

2211

1.41

10.17

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3233

20884

1.14

10.16

3.2

4.0

79.35

89.37

ng/l

9.65

2810

18171

(3011985) Renin [Units/volume] in Plasma

733

4119

1.30

10.10

1.4

1.6

67.04

61.69

mu/l

0.29

662

3692

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

106

382

2.02

10.03

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1863

11574

1.18

9.98

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1854

11520

1.18

9.92

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1863

11581

1.18

9.91

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

212

951

1.63

9.83

1.2

1.3

13.29

21.46

0.92

173

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

130

508

1.87

9.75

1.2

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

662

3688

1.31

9.74

1.8

90.15

90.18

0.05

652

3628

(3014051) Protein [Presence] in Urine by Test strip

1278

7693

1.22

9.71

2.3

2.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

332

1651

1.47

9.70

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1856

11556

1.18

9.69

1.3

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1318

7965

1.21

9.62

4.2

4.5

3.83

3.86

mmol/l

1.91

1313

7898

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

678

3800

1.30

9.55

1.3

1.4

345.16

387.63

pmol/l

0.50

608

3328

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1368

8310

1.20

9.47

2.0

2.4

0.69

0.79

g/l

0.50

1185

7173

(3028271) Lactate [Moles/volume] in Capillary blood

786

4498

1.28

9.44

1.9

1.8

1.79

1.74

mmol/l

0.60

763

4396

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

108

402

1.96

9.37

1.1

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

296

1449

1.49

9.37

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

376

1932

1.42

9.26

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1553

9576

1.19

9.13

1.4

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3459

28021

0.89

9.05

3.2

4.1

12.04

24.08

ug/l

2.85

2593

22279

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

317

1586

1.46

9.02

1.2

1.3

65.47

64.57

0.05

199

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

251

1198

1.53

8.98

1.5

1.8

28.97

29.18

umol/l

0.12

235

1160

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

135

549

1.79

8.97

1.1

—

(3004775) Volume in Urine collected for unspecified duration

194

2220

0.64

8.90

2.0

2.3

695.44

668.52

0.38

134

1563

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

140

578

1.77

8.85

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

111

426

1.90

8.84

1.8

1.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

865

5055

1.25

8.75

2.3

2.1

3.48

7.29

titre

1.31

149

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1498

9245

1.19

8.73

1.9

2.3

2.86

2.93

g/l

2.24

1331

8302

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

319

1611

1.44

8.67

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

584

5507

0.77

8.64

2.6

3.4

312.55

892.28

u/ml

2.10

519

5016

(3036489) Thrombin time

1882

11846

1.16

8.61

1.8

2.2

20.78

21.38

5.68

1589

10197

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

364

1.96

8.60

1.0

0.30

0.19

u/ml

0.36

219

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

543

3000

1.32

8.55

4.0

4.8

133.51

107.70

u/ml

0.31

147

974

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

226

1067

1.54

8.52

1.1

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1975

12493

1.16

8.47

3.1

2.9

1.49

1.28

8.61

1967

12428

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

313

1583

1.44

8.45

1.9

126.64

141.67

3.77

298

1487

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

311

1573

1.44

8.40

1.1

12.88

9.39

u/ml

0.70

282

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3845

25381

1.11

8.37

7.4

8.3

123.59

121.72

g/l

6.75

3763

24654

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

274

2.10

8.34

1.2

46.74

48.47

mg/l

0.14

(3005033) Fetal Nuchal fold Thickness US

1509

9358

1.18

8.33

1.4

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

229

1091

1.53

8.31

1.2

108.74

111.42

0.79

203

975

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1511

9376

1.18

8.29

1.4

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

898

5314

1.23

8.14

1.3

1.2

3.97

3.62

u/ml

0.22

300

1823

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

227

1088

1.52

8.03

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

661

3785

1.28

7.98

1.3

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1929

12236

1.15

7.98

3.1

2.9

0.64

0.66

1.89

1923

12189

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

667

3824

1.27

7.98

1.3

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

236

1143

1.51

7.95

1.1

115.31

109.58

1.37

207

1033

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2622

16982

1.13

7.95

3.0

3.4

5.12

5.15

kpa

1.37

2489

16076

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

660

3781

1.27

7.94

1.3

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2505

16181

1.13

7.93

3.0

3.4

1.48

1.68

mmol/l

2.23

1801

11882

(3009343) pH of Capillary blood

2588

16753

1.13

7.92

3.0

3.4

7.42

0.23

363

2239

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.36

7.87

1.9

1.4

236.46

297.79

nmol/l

0.24

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1078

6525

1.21

7.84

2.0

2.2

132.97

130.69

g/l

2.25

759

4817

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

338

1759

1.40

7.83

1.4

1.5

6.16

5.70

u/l

0.38

285

1480

(3011841) English Walnut IgE Ab [Units/volume] in Serum

316

1.98

7.82

1.0

0.34

1.07

u/ml

0.79

233

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

234

2.15

7.74

1.0

0.29

0.91

u/ml

0.66

150

(3025468) Yersinia sp identified in Specimen by Organism specific culture

658

3781

1.27

7.74

1.3

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

134

571

1.71

7.66

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

679

3922

1.26

7.66

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

838

4957

1.23

7.66

1.1

120.30

118.71

0.78

751

4492

(3021788) Differential panel - Synovial fluid

877

5216

1.23

7.61

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

665

3838

1.27

7.56

1.3

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

865

5155

1.23

7.38

1.3

1.2

3.84

3.94

u/ml

0.09

373

2331

(40768443) Skin Pathology biopsy report

2047

13118

1.14

7.35

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

445

2448

1.33

7.30

1.2

1.3

1.89

2.07

mmol/l

2.90

411

2272

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

864

5156

1.22

7.29

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

229

1125

1.48

7.26

1.1

96.13

91.54

1.34

529

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

238

1182

1.47

7.15

1.2

0.30

0.31

g/l

0.96

180

945

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

181

849

1.55

7.12

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

115

480

1.75

7.11

1.3

0.28

0.26

nmol/l

0.14

349

(3001556) Androgen free Index in Serum or Plasma

102

412

1.80

7.04

1.3

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

153

692

1.61

7.02

1.0

5.05

1.19

u/ml

0.44

126

583

(3020650) Glucose [Presence] in Urine

185

876

1.54

6.99

1.5

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

223

1099

1.48

6.98

1.1

101.65

92.49

2.60

522

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1593

10074

1.16

6.93

1.6

229.25

306.62

titre

0.66

401

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

290

1.96

6.92

1.0

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

990

6021

1.20

6.90

2.3

2.5

16.90

16.58

1.44

475

3068

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

179

2.24

6.86

1.1

1.2

2.26

4.01

u/ml

0.38

147

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

394

2152

1.34

6.83

1.2

1.1

1.05

1.07

ratio

2.32

159

739

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

134

591

1.65

6.80

1.1

0.85

3.28

u/ml

2.03

422

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

323

1.90

6.77

1.0

0.35

0.52

u/ml

0.30

186

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

274

1413

1.41

6.77

1.8

2.3

20.85

158.68

ug/l

1.90

259

1350

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1337

8361

1.17

6.75

1.9

2.1

10.25

10.78

mg/l

1.92

1244

7827

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

304

1598

1.39

6.72

1.0

259.63

344.84

ng/l

2.97

230

1141

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

345

1.86

6.70

1.0

0.02

0.26

u/ml

1.20

194

(3051101) Glucose [Moles/volume] in Cord blood

444

0.31

6.69

4.1

5.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1329

8317

1.17

6.65

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2268

14730

1.13

6.63

2.5

2.6

0.27

0.28

e6/l

0.10

2179

14298

(3004588) Protein electrophoresis panel - Serum or Plasma

2646

17352

1.12

6.55

1.9

2.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

353

1.84

6.54

1.0

0.10

2.15

u/ml

0.82

192

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

434

2420

1.31

6.53

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1976

12746

1.13

6.46

1.4

1.6

10.86

13.83

u/ml

0.43

386

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

304

1611

1.38

6.43

1.0

33.77

42.94

ng/l

3.85

227

1127

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

199

2.12

6.40

1.0

26.24

17.29

u/ml

0.49

162

(3045716) Anion gap in Serum or Plasma

236

1198

1.44

6.39

2.3

2.4

9.68

9.83

mmol/l

0.27

229

1162

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

128

569

1.64

6.34

1.3

1.5

5.64

5.93

nmol/l

0.40

120

545

(3042733) HLA Ab [Presence] in Serum

1200

0.59

6.34

4.9

5.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

853

5162

1.21

6.32

1.7

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

160

752

1.55

6.30

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

688

4076

1.23

6.29

1.2

53.54

51.80

u/ml

0.06

268

(3004616) Nuclear Ab [Presence] in Serum

648

3818

1.24

6.24

1.4

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1446

9158

1.15

6.21

1.8

2.3

9.94

10.15

g/l

1.19

1273

8167

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

213

1067

1.46

6.20

2.7

2.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

302

1610

1.37

6.18

1.0

785.44

746.62

ng/l

0.78

212

1114

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

164

2.22

6.17

1.4

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

137

1550

0.64

6.14

36.3

37.0

7.28

7.42

ug/l

0.48

127

1423

(3044941) Cell count panel - Synovial fluid

733

4385

1.22

6.12

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

194

958

1.48

6.08

1.1

—

(3016038) Potassium [Moles/volume] in Urine

315

1696

1.35

6.06

1.2

31.09

34.20

mmol/l

1.79

269

1469

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

402

2244

1.31

6.04

1.1

1.2

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

1.45

1.23

mg/l

0.15

153

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

1.66

2.96

mg/l

1.50

176

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

4.09

3.94

mg/l

0.06

157

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

2.39

2.07

mg/l

0.16

159

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

2.25

1.79

mg/l

0.37

183

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

2.15

2.37

mg/l

0.16

174

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

1.73

2.01

mg/l

0.18

154

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

2.13

2.29

mg/l

0.09

186

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

259

1.94

6.02

1.6

0.82

0.92

mg/l

0.11

164

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

356

1956

1.33

5.99

2.4

3.2

72.06

130.50

nmol/l

8.14

347

1918

(4035726) Immunohistochemistry procedure

3232

25700

0.91

5.94

1.3

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

202

1013

1.45

5.87

1.1

0.95

13.22

u/ml

0.69

118

561

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

267

1.91

5.84

1.6

1.79

1.85

mg/l

0.03

168

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7470

57420

0.94

5.69

4.0

3.8

21.47

21.85

1.13

2957

24871

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

226

1167

1.41

5.63

1.8

2.0

140.47

165.20

4.53

206

1103

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.79

5.53

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

320

1.80

5.50

1.0

1.14

1.51

u/ml

0.13

229

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1448

9258

1.14

5.49

2.2

2.6

172.88

184.63

5.83

1357

8764

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1532

9832

1.14

5.49

1.9

2.3

7.20

7.38

g/l

3.85

1365

8885

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1530

9819

1.14

5.48

1.9

2.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

238

1.93

5.44

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

1740

14225

0.89

5.43

2.9

3.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

213

1.98

5.42

1.0

0.66

2.02

u/ml

0.94

165

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

339

1879

1.32

5.42

1.1

1.07

u/l

0.07

132

850

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1526

9804

1.14

5.38

1.9

2.3

3.69

3.68

g/l

0.15

1364

8864

(3007700) Barley IgE Ab [Units/volume] in Serum

155

2.16

5.37

1.0

0.25

9.60

u/ml

0.51

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

218

1130

1.41

5.34

1.1

1.0

10.74

12.12

u/ml

0.38

124

654

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

227

0.26

5.32

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

266

1.86

5.30

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

395

1.70

5.27

1.4

1.2

—

(3024471) HLA-A [Type]

101

1174

0.63

5.20

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1588

10254

1.13

5.19

1.6

10.69

5.24

iu/ml

0.25

315

2119

(3003434) Protein [Mass/volume] in Pleural fluid

333

3141

0.77

5.15

1.5

1.4

33.24

33.64

g/l

0.23

302

2842

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

346

1939

1.30

5.13

1.6

2.1

100.34

98.27

0.54

309

1803

(3024932) HLA-DR beta [Type]

1150

0.63

5.09

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

423

2437

1.27

5.06

1.1

296.71

411.64

mg/l

0.46

382

2192

(3019060) Gas panel - Arterial blood

2618

17419

1.10

4.97

4.4

4.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3202

21504

1.09

4.96

2.0

2.6

67.03

66.59

g/l

2.70

2888

19642

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

423

2446

1.26

4.92

3.5

4.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

386

2214

1.27

4.81

2.8

2.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

533

3171

1.23

4.81

1.2

63.83

63.19

u/l

0.06

467

2853

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

208

1.93

4.78

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

631

0.52

4.70

1.3

34.77

338.72

ug/l

3.55

338

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

750

4621

1.18

4.69

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.59

4.68

1.1

—

mmol/l

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

280

1546

1.32

4.67

1.3

106.96

70.31

titre

0.28

127

(3018001) Oat IgE Ab [Units/volume] in Serum

236

1.85

4.65

1.0

0.21

0.83

u/ml

0.79

138

(3010015) Selenium [Moles/volume] in Serum or Plasma

252

1.82

4.64

1.6

2.0

1.28

1.34

umol/l

0.74

226

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

219

2150

0.74

4.58

1.3

497.69

508.23

u/l

0.03

205

2035

(3010375) cycloSPORINE [Mass/volume] in Blood

136

1443

0.69

4.55

21.7

27.1

108.76

118.69

ug/l

1.06

109

1188

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

286

1591

1.31

4.54

1.3

205.00

462.40

titre

1.29

(3007930) Methemoglobin/Hemoglobin.total in Blood

1356

11121

0.89

4.53

4.7

5.1

0.91

0.90

0.24

1276

10408

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

132

644

1.49

4.52

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4611

31530

1.07

4.51

3.3

4.3

226.72

242.63

u/l

14.05

4323

29901

(3006270) Folate [Moles/volume] in Blood

408

2376

1.25

4.51

1.1

1.2

397.01

374.64

nmol/l

1.52

384

2013

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

110

516

1.55

4.51

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

132

645

1.49

4.49

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

132

646

1.49

4.46

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

206

2024

0.74

4.36

1.5

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

878

5515

1.16

4.36

1.9

5.33

5.24

mmol/24h

0.35

775

4938

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

933

1.40

4.34

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

278

1551

1.31

4.34

1.1

95.61

97.87

0.64

213

1246

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

598

3641

1.20

4.31

1.1

98.43

95.42

1.98

557

3416

(3028626) Oxygen [Partial pressure] in Capillary blood

973

6164

1.15

4.31

2.7

3.1

8.47

8.39

kpa

0.87

952

6019

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

783

4885

1.17

4.25

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1206

7760

1.13

4.25

1.2

1.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

223

1.83

4.22

1.0

0.49

0.52

u/ml

0.05

123

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1598

10466

1.12

4.19

3.2

3.7

24.66

24.83

mmol/l

2.01

1512

9689

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1391

11326

0.89

4.15

4.5

5.0

1.85

1.69

3.80

1306

10597

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

514

3098

1.21

4.14

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

742

4622

1.17

4.12

1.4

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

209

1.85

4.12

1.0

1.15

0.45

u/ml

0.54

190

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

539

3269

1.20

4.08

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

256

1426

1.31

4.07

1.9

2.1

19.30

24.73

umol/l

0.40

135

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

314

1797

1.27

4.06

1.6

1.5

24.82

23.36

u/ml

0.21

334

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

778

4873

1.17

4.04

1.3

1.4

6.86

7.00

mmol/l

0.77

723

4327

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

164

854

1.40

4.03

1.5

1.6

8.87

8.93

ug/l

0.05

164

854

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

287

1628

1.29

3.99

1.1

1530.42

1491.60

miu/ml

0.22

287

1628

(3013466) aPTT in Blood by Coagulation assay

201

1.85

3.99

1.2

1.1

35.46

36.46

0.68

170

(3000475) Leukocytes [#/volume] in Synovial fluid

1063

6824

1.14

3.92

1.6

9085.51

13453.93

e6/l

4.29

757

4987

(40768806) Pleura Pathology biopsy report

258

2417

0.78

3.90

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

723

0.59

3.90

1.3

3.52

3.39

mmol/l

0.10

663

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

788

6624

0.86

3.88

2.1

2.3

115.57

108.44

ug/min

0.14

459

3994

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

112

2.15

3.88

1.5

1.3

372.95

527.21

nmol/l

1.31

112

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

432

2583

1.22

3.81

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

120

597

1.46

3.80

1.3

1.2

95.73

42.55

mg/l

0.42

430

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

430

2571

1.22

3.80

1.5

1.3

1.51

1.43

nmol/l

0.82

400

2312

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

431

2578

1.22

3.79

1.1

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1072

6902

1.13

3.79

2.6

2.9

24.36

24.68

mmol/l

1.85

1046

6740

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

896

5701

1.15

3.79

1.2

163.33

130.55

titre

—

127

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

431

2580

1.22

3.77

1.1

1.2

—

(3016750) Collection duration of Urine

170

1675

0.74

3.74

1.9

2.2

507.09

498.71

min

0.55

117

1284

(40768793) Breast Pathology biopsy report

1118

7228

1.13

3.71

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

216

1193

1.32

3.70

2.3

2.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

128

649

1.44

3.69

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

191

1.83

3.67

1.5

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

410

2450

1.22

3.66

1.3

1.2

38.96

51.14

u/ml

—

120

(3023420) DNA double strand Ab [Units/volume] in Serum

585

3615

1.18

3.64

1.6

30.20

35.48

iu/ml

0.51

162

(3001893) Eosinophils/100 leukocytes in Pleural fluid

718

0.61

3.64

1.4

3.95

2.81

0.37

610

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1535

10118

1.11

3.63

1.9

2.4

95.26

93.24

3.08

1452

9700

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1276

10350

0.90

3.61

2.0

1.95

2.32

ug/l

0.64

1122

9144

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

575

3551

1.18

3.61

2.4

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

290

1672

1.26

3.59

1.2

2.97

14.64

u/ml

2.53

171

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

214

1.77

3.58

1.1

1.0

15.58

6.93

u/ml

1.07

153

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1203

9784

0.89

3.58

3.0

3.5

314.67

1979.17

u/ml

1.74

1027

8371

(3035947) Staphylolysin Ab [Units/volume] in Serum

255

1449

1.28

3.55

1.1

3.80

3.65

iu/ml

0.09

115

(3035933) Granulocytes/100 leukocytes in Blood

165

881

1.37

3.55

2.1

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

116

583

1.45

3.52

1.7

1.8

—

(3051651) Icteric interference index of Serum or Plasma

298

1729

1.26

3.51

3.0

3.8

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

2.73

3.50

1.0

1.4

196.33

165.76

nmol/l

0.18

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

302

1757

1.25

3.48

1.2

25.61

23.13

u/l

0.31

249

1523

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1825

12161

1.10

3.47

1.7

1.8

1.47

1.51

g/l

0.98

1556

10418

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

424

2559

1.21

3.45

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

275

1584

1.27

3.45

1.4

1.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

384

2296

1.22

3.44

1.2

4.98

11.02

u/ml

0.98

164

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

399

2395

1.21

3.44

1.2

55.20

43.40

u/ml

0.41

187

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

398

2389

1.21

3.43

1.2

57.95

70.82

u/ml

0.47

111

(3051387) C reactive protein [Mass/volume] in Capillary blood

777

6473

0.87

3.42

3.7

3.2

21.95

26.06

mg/l

2.58

444

4058

(3007542) Rye IgE Ab [Units/volume] in Serum

180

1.82

3.41

1.0

0.21

10.81

u/ml

0.52

(40759836) Histone Ab [Presence] in Serum by Immunoblot

423

2556

1.21

3.41

1.1

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

677

4258

1.16

3.41

1.1

1.48

1.49

g/l

0.41

617

3856

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

217

1219

1.30

3.33

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

423

2563

1.20

3.32

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

780

4969

1.15

3.30

2.4

2.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

188

1.78

3.27

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

123

636

1.41

3.24

1.1

1.35

2.88

umol/24h

0.30

323

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1247

8186

1.11

3.23

1.3

1.5

11.34

15.36

iu/ml

0.87

199

(3036071) Salmonella sp Ab [Titer] in Serum

196

1091

1.31

3.23

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

307

1807

1.24

3.22

1.2

85.28

88.22

u/l

0.20

257

1591

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

213

1200

1.29

3.21

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

674

1.39

3.20

1.0

1.1

—

(3022313) Gas panel - Capillary blood

1784

11930

1.09

3.18

3.1

3.6

—

(3012441) Differential panel - Pleural fluid

268

2430

0.80

3.16

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

388

1.52

3.15

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1142

7474

1.12

3.14

1.4

—

(40768800) Prostate Pathology biopsy report

457

3930

0.85

3.11

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

483

2982

1.18

3.11

2.8

3.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

319

2834

0.82

3.10

1.5

5297.63

3506.03

e6/l

0.56

218

2051

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

142

761

1.36

3.05

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

415

1.49

3.04

1.7

1.4

269122.33

215734.55

nmol/l

0.10

337

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

214

1218

1.28

3.01

1.1

1302.00

396.18

ng/l

0.38

276

(3028308) Erythrocytes [#/volume] in Pleural fluid

287

2566

0.81

2.99

1.5

1.4

72603.68

49418.27

e6/l

0.29

162

1527

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

146

789

1.35

2.98

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

411

1.49

2.98

1.0

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

137

734

1.36

2.96

1.1

1.2

109.10

108.26

0.12

124

696

(40761539) Cells [Type] in Urine sediment by Light microscopy

133

710

1.37

2.94

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

504

3142

1.17

2.91

1.4

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1057

6926

1.11

2.88

1.3

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

387

1.49

2.81

2.4

2.6

—

(3035880) pH of Pleural fluid

133

1294

0.75

2.80

1.2

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

187

1.71

2.79

1.5

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

581

0.63

2.77

1.4

19.56

23.97

0.59

483

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

397

0.55

2.76

4.0

3.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

11318

84726

0.97

2.72

3.5

3.9

7.90

9.41

mg/mmol

2.77

7029

53482

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

167

1.74

2.71

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

507

3183

1.16

2.71

3.6

6.5

7.26

7.29

mmol/l

0.03

416

2595

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.08

2.70

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

979

6418

1.11

2.68

1.3

1.5

102.79

111.49

u/ml

2.24

250

1428

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

350

3033

0.84

2.67

1.9

29.48

23.35

ug/l

0.39

342

2963

(3007919) Fasciola sp Ab [Titer] in Serum

2.48

2.64

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

201

1157

1.27

2.64

3.9

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

140

768

1.33

2.63

1.1

6.41

6.96

mg/g

0.34

135

726

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

852

0.70

2.63

1.4

57.97

61.75

0.48

702

(40768446) Kidney Pathology biopsy report

139

1329

0.76

2.61

1.8

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

130

708

1.34

2.58

1.1

1.2

102.17

86.96

1.48

202

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

595

3796

1.14

2.56

1.1

0.62

2.17

iu/ml

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.07

2.56

1.0

0.29

0.65

u/ml

0.83

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

522

3304

1.15

2.53

1.3

1.4

8.25

7.98

mmol/l

0.71

511

3192

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

185

1061

1.27

2.52

2.6

3.0

27.11

28.61

umol/l

0.90

132

811

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

183

1679

0.79

2.49

1.3

13.38

14.46

u/l

0.34

168

1543

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

306

1860

1.20

2.44

1.6

6.07

6.92

u/l

0.53

233

1491

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

507

3212

1.15

2.44

2.6

3.3

3.94

7.55

nmol/l

1.28

493

3107

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1041

6888

1.10

2.42

1.3

1.5

32.19

19.42

u/ml

0.91

141

(3004541) Aldosterone [Moles/volume] in Urine

7.28

2.42

1.4

1.2

—

(3045788) Cell count panel - Pleural fluid

246

2178

0.82

2.41

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2457

16837

1.07

2.39

6.8

7.1

24.53

24.60

mmol/l

0.39

2364

15982

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.22

2.39

1.1

2.7

1.24

2.10

mu/l

1.44

(40765096) Chromosome analysis panel by Banding

784

0.71

2.38

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

460

0.62

2.36

1.8

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

531

0.64

2.35

1.1

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

359

0.57

2.35

1.3

1.4

6.88

13.47

1.58

185

(3016330) Potassium [Moles/time] in 24 hour Urine

477

1.39

2.33

1.3

1.2

88.69

75.39

mmol/24h

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

111

601

1.35

2.33

1.7

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

128

708

1.32

2.32

1.1

1.2

82.57

75.36

0.34

192

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

203

0.43

2.32

3.2

6.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

447

1.40

2.31

1.0

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

204

1.61

2.30

1.1

37.29

27.26

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

204

1.61

2.30

1.1

16.66

23.72

u/ml

—

(3004809) Band form neutrophils/100 leukocytes in Blood

560

4625

0.88

2.30

2.4

3.2

1.40

1.51

0.35

489

4140

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

212

0.45

2.29

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

351

1.45

2.28

1.9

2.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

614

0.68

2.28

5.9

5.5

—

(3024263) Appearance of Synovial fluid

242

1455

1.21

2.20

1.5

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

140

791

1.29

2.20

1.3

16.78

16.93

umol/l

0.15

126

703

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

144

1335

0.78

2.19

2.3

2.1

30.41

113.14

ug/min

3.24

309

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

197

1166

1.23

2.11

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3441

23913

1.05

2.09

5.8

8.0

8.17

9.35

mmol/l

21.66

3285

22803

(3013862) HLA-DP [Type]

130

0.39

2.07

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

494

1.36

2.07

1.0

0.34

0.23

u/ml

0.14

303

(40757373) Influenza virus identified in Isolate

566

0.68

2.06

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

120

0.36

2.06

3.0

2.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.50

2.04

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

758

4987

1.11

2.04

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1102

7383

1.09

2.02

1.3

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

443

3676

0.88

2.01

5.6

6.5

11.05

11.31

mg/l

0.56

411

3366

(40759632) Porphyrins [Mass/mass] in Stool

2.58

1.99

1.3

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

161

1.63

1.98

1.2

1.1

1.12

1.22

u/field

0.49

107

(3030313) Adrenal Ab [Titer] in Serum

350

1.42

1.98

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

127

0.40

1.95

1.0

—

(40760410) HLA-B [Type] by High resolution

127

0.40

1.95

1.0

—

(40763590) HLA-DQ beta [Type]

127

0.40

1.95

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

216

1303

1.21

1.95

2.3

2.5

49.68

51.27

umol/l

0.30

188

1125

(46236302) HLA-C [Type] by High resolution typing

128

0.40

1.94

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

436

0.65

1.92

5.5

6.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2363

16299

1.06

1.92

3.2

3.4

132.37

129.41

g/l

9.08

2313

15908

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

476

1.35

1.92

1.8

1.19

mmol/l

0.15

457

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

318

1988

1.17

1.91

1.6

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

144

1309

0.80

1.90

2.8

3.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

251

1.48

1.88

1.4

8.18

13.69

pmol/l

1.14

216

(3014148) Varicella zoster virus Ab [Titer] in Serum

725

4783

1.11

1.88

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

466

1.34

1.86

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

349

2925

0.87

1.86

1.2

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

587

0.71

1.85

1.0

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

114

1.73

1.84

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1397

9489

1.07

1.84

2.2

2.8

3.61

3.62

g/l

0.02

1310

9038

(40758292) HTLV I+II Ab panel - Serum

561

0.70

1.84

1.3

1.4

—

(3047189) Immunofixation for 24 hour Urine

125

1149

0.79

1.83

1.7

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

103

575

1.31

1.83

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

670

0.73

1.82

11.0

8.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

154

1.61

1.81

1.1

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

3.64

1.80

1.2

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

114

0.38

1.79

1.7

2.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1112

8739

0.93

1.79

2.9

3.3

0.36

0.35

u/ml

0.26

617

4977

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

218

1330

1.19

1.78

2.5

2.6

115.98

161.47

au/ml

1.09

181

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

314

1975

1.16

1.77

1.1

—

(4146454) Self-monitoring of blood glucose

343

2866

0.87

1.77

2.6

2.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

346

1.39

1.77

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

121

696

1.27

1.73

1.6

0.41

0.39

ug/l

0.13

465

(3017704) Immunofixation for Urine

157

1397

0.82

1.73

1.5

1.6

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.97

1.72

1.1

1.0

3.45

0.37

u/ml

0.56

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

273

0.59

1.72

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

198

0.51

1.71

1.1

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

235

1450

1.18

1.70

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

426

2746

1.13

1.70

1.5

1.6

34.82

32.35

0.66

258

1712

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

826

5521

1.09

1.67

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

106

603

1.28

1.66

1.3

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

452

1.32

1.63

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

165

0.49

1.62

2.5

3.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

222

0.56

1.62

1.1

1.2

14.80

17.52

g/l

1.41

196

(3044927) Protein electrophoresis panel - Urine

292

2447

0.87

1.61

1.2

—

(3019977) pH of Arterial blood

235

1459

1.17

1.60

2.9

2.5

7.42

0.03

510

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

137

808

1.24

1.60

2.7

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

137

808

1.24

1.60

2.7

2.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

363

2327

1.14

1.60

1.3

1.4

11.15

11.89

umol/l

1.27

347

2207

(3020876) Protein [Mass/time] in 24 hour Urine

362

2987

0.88

1.59

2.3

2.6

1.07

1.30

g/24h

1.01

156

1531

(3022670) pH of Venous cord blood

1.94

1.59

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4983

35147

1.04

1.57

4.3

4.2

32.00

32.18

0.57

3608

25010

(3017569) Oxygen content in Arterial blood

191

1168

1.19

1.56

2.6

2.1

—

(3022475) Manganese [Moles/volume] in Blood

196

1.49

1.56

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

110

1003

0.80

1.56

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

324

1.37

1.55

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

133

786

1.23

1.54

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

387

1.34

1.54

1.8

1.7

1.42

1.74

mg/l

1.68

329

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

234

1461

1.17

1.51

3.0

3.1

8.86

8.09

mg/l

0.73

181

1175

(3008536) Aspergillus sp Ab [Presence] in Serum

597

0.74

1.50

1.4

2.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

121

1086

0.81

1.49

1.4

1.7

9906.00

30662.52

u/ml

—

128

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

205

1268

1.18

1.49

2.0

9.46

9.29

mg/l

0.16

163

1018

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

517

1.28

1.48

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

785

0.78

1.48

1.5

1.9

35.19

33.14

u/l

0.04

711

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

231

1444

1.17

1.47

1.1

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

244

1532

1.16

1.47

1.2

1.1

80.17

84.91

u/l

0.37

220

1385

(42529582) MDA5 Ab [Presence] in Serum by Line blot

121

712

1.24

1.47

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

121

712

1.24

1.47

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

121

712

1.24

1.47

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

121

712

1.24

1.47

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

167

1016

1.20

1.46

1.8

1.7

153.39

130.34

au/ml

0.20

138

(3033799) Differential panel - Peritoneal fluid

816

0.79

1.46

2.1

1.9

—

(3033942) Copper [Moles/time] in 24 hour Urine

146

1.55

1.45

1.2

1.38

0.77

umol/24h

0.33

(3038071) Oxygen [Partial pressure] in Mixed venous blood

584

0.75

1.43

11.8

8.7

—

(3018572) Chloride [Moles/volume] in Blood

795

6262

0.92

1.43

5.9

6.8

104.77

105.19

mmol/l

1.51

729

5622

(3023487) Leukocytes [#/volume] in Peritoneal fluid

106

959

0.80

1.42

2.0

702.06

2954.00

e6/l

1.33

647

(3039000) Anion gap in Blood

795

6261

0.92

1.42

5.9

6.8

11.44

11.21

mmol/l

1.19

729

5620

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

342

1.34

1.42

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

231

0.60

1.42

2.8

2.3

71.00

58.80

—

142

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

176

1080

1.19

1.41

1.1

—

(3037756) Immunofixation for Serum or Plasma

664

5263

0.92

1.39

1.4

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

243

1533

1.16

1.39

1.2

1.1

22.71

24.36

u/l

0.17

220

1389

(3008757) Leukocyte morphology finding [Identifier] in Blood

375

3056

0.89

1.38

2.7

3.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

220

1.42

1.38

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

287

1836

1.14

1.36

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

765

6018

0.92

1.35

2.6

3.4

—

(3008896) Cortisol [Moles/volume] in Urine

3.03

1.34

1.2

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

629

4204

1.09

1.34

1.3

29.71

35.11

u/l

0.34

553

3662

(3010370) Gastrin [Moles/volume] in Serum or Plasma

480

1.27

1.33

1.7

1.8

41.97

58.91

pmol/l

0.43

412

(40761995) Spermatozoa Progressive [#/volume] in Semen

120

1062

0.82

1.33

3.0

3.2

—

(3019174) dRVVT (LA screen)

315

1.34

1.32

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

120

1061

0.82

1.32

6.0

6.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

204

1.43

1.31

1.0

1.1

8.98

8.97

u/l

0.00

204

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.77

1.31

1.5

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.45

1.31

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

665

0.78

1.31

1.5

1.4

13.67

13.59

g/l

0.02

502

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

223

1.40

1.30

1.3

1.5

40.87

36.05

0.34

151

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.93

1.30

1.1

1.0

0.04

0.24

u/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

615

4117

1.09

1.28

1.4

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.05

1.28

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

160

0.55

1.28

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

249

1.37

1.26

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

2.80

1.24

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

165

1.46

1.22

1.2

1.4

2.12

1.59

0.20

108

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

301

1.33

1.22

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.43

1.21

1.7

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.43

1.21

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

308

0.69

1.21

1.3

32.74

186.89

u/l

0.91

224

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.64

1.21

1.2

—

(3044007) Cell count panel - Peritoneal fluid

762

0.80

1.20

1.9

—

(3020491) Glucose [Moles/volume] in Blood

360

2357

1.11

1.20

1.5

1.8

6.56

6.60

mmol/l

0.10

295

1740

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

398

2621

1.11

1.19

1.2

230.00

187.23

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

399

2629

1.11

1.18

1.2

167.79

201.56

titre

0.37

443

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

224

1857

0.88

1.15

2.6

2.8

42.99

39.73

2.01

123

1020

(36303858) Crystals [Presence] in Urine

1.95

1.14

1.0

1.2

—

(4212803) Bone marrow aspirate examination

223

1.37

1.14

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

250

1609

1.13

1.5

1.7

2.44

2.37

u/field

0.06

188

1157

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

300

1953

1.12

1.13

6.2

6.6

—

(3029075) Extractable nuclear Ab panel - Serum

156

971

1.17

1.12

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

151

938

1.17

1.12

1.8

2.1

168.47

359.10

e6/l

1.30

498

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.32

1.11

1.1

1.0

—

(3012516) Albumin [Mass/volume] in Urine

10899

80662

0.98

1.11

3.0

3.3

481.78

416.60

mg/l

0.64

6885

51152

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

306

1.31

1.11

1.1

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

212

1.37

1.10

1.8

52.42

45.93

umol/l

0.43

212

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

188

0.62

1.09

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

307

1.31

1.09

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

426

0.75

1.08

7.6

6.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

772

6007

0.94

1.07

1.5

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

127

783

1.18

1.04

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

131

811

1.18

1.03

1.5

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

407

1.25

1.03

1.4

1.6

—

(4281824) Cell count and differential, peritoneal fluid

424

3369

0.92

1.03

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

221

1815

0.89

1.01

1.2

1.4

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.57

1.01

1.0

0.05

0.09

u/ml

0.33

(3006598) pH of Arterial cord blood

1.55

1.00

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

396

1.25

0.99

1.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

295

1937

1.11

0.99

1.3

1.4

5.44

5.55

mmol/l

0.81

279

1836

(3039443) Prostate specific Ag panel - Serum or Plasma

667

5196

0.93

0.99

1.5

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

510

3436

1.08

0.98

1.5

1.6

7.61

7.63

mmol/l

0.10

496

3291

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

218

1787

0.89

0.98

1.2

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

118

729

1.18

0.97

1.2

1.1

253.33

560.00

titre

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

224

1.33

0.96

3.2

2.9

10.67

410.40

pmol/l

0.66

(3000034) Microalbumin [Mass/volume] in Urine

386

2573

1.09

0.96

3.0

2.9

46.80

54.32

mg/l

0.27

278

1815

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

317

0.74

0.95

2.2

3.1

1.88

1.21

mg/l

0.65

206

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

181

1.37

0.94

1.3

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

1.77

0.94

1.0

—

0.05

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

132

1.43

0.93

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

328

1.27

0.93

1.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.75

0.93

1.0

422.80

365.69

umol/l

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

188

1.36

0.92

1.7

2.0

2.14

9.95

nmol/l

1.89

175

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

348

2771

0.91

1.3

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

498

3905

0.93

0.91

1.2

—

(3035060) Mercury [Moles/volume] in Blood

1.78

0.90

2.5

1.4

17.08

9.38

nmol/l

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

534

1.20

0.90

2.3

2.6

34.38

50.31

mg/l

0.44

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

127

796

1.16

0.89

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

240

1.31

0.89

1.1

—

2.44

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.08

0.89

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

171

1.36

0.88

1.0

1.1

2.96

2.85

u/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

842

0.85

0.88

1.9

1.8

15786.85

11423.03

e6/l

0.18

441

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

299

1.27

0.87

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

395

2651

1.09

0.87

1.4

88563.30

103611.06

e6/l

0.22

280

1803

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

270

0.73

0.86

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

721

0.84

0.85

1.1

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1159

8062

1.05

0.84

2.6

3.6

1.36

1.48

mg/l

6.40

1071

7460

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

217

1.31

0.84

1.2

1.1

13.99

15.28

nmol/l

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.53

0.83

1.0

0.01

0.20

u/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

624

0.83

2.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

118

741

1.16

0.83

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

199

1.32

0.81

1.4

1.5

12.86

13.24

0.04

144

(3028433) Virus identified in Specimen by Culture

158

1015

1.13

0.81

1.2

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

193

1.32

0.81

1.3

1.4

20.83

16.74

pmol/l

0.29

162

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

355

1.23

0.80

2.5

3.2

42.70

41.77

umol/l

0.10

306

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.80

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.80

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.71

0.80

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

303

1.25

0.80

1.7

1.5

112.78

115.27

ug/l

0.06

247

(21494890) Protein electrophoresis panel - 24 hour Urine

331

2620

0.92

0.80

1.8

2.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.55

0.79

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

399

2694

1.08

0.78

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

332

2225

1.09

0.78

2.0

2.6

534.50

522.54

e6/l

0.15

269

1869

(3001729) Color of Synovial fluid

231

0.73

0.78

2.4

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

707

4869

1.06

0.77

1.4

1.5

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.60

0.77

1.2

1.3

106.50

47.84

e6/l

—

(3003577) Lead [Moles/volume] in Blood

259

1.27

0.77

1.8

1.4

0.20

0.22

umol/l

0.20

(3001218) Citrate [Mass/time] in 24 hour Urine

1.73

0.77

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

662

5103

0.94

0.76

2.9

3.7

37.23

38.04

u/ml

0.03

637

4930

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.72

0.76

1.7

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

240

1.27

0.76

1.0

—

(3047181) Lactate [Moles/volume] in Blood

1299

9087

1.04

0.76

4.7

5.7

1.28

1.30

mmol/l

0.27

1151

8027

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

213

0.72

0.76

2.3

2.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

221

1.29

0.75

1.1

1.3

21.28

21.61

mmol/l

0.16

158

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.14

0.75

1.0

1.1

24.00

32.53

umol/l

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.60

0.75

1.0

—

(21494434) Karyotype in Bone marrow

279

2216

0.92

0.74

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

600

0.84

0.74

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

140

1152

0.88

0.73

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

140

1152

0.88

0.73

1.7

2.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

534

1.17

0.72

1.2

1.4

59.11

250.05

ng/l

0.65

346

(3011325) HIV 1+2 Ab [Presence] in Serum

165

1.32

0.72

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

287

2272

0.92

0.72

1.3

6.50

6.28

mmol/l

0.60

268

2100

(3029396) Erythrocyte agglutination [Presence] in Blood

188

1234

1.11

0.71

2.9

3.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

722

4993

1.05

0.70

1.1

66.62

2769.33

iu/ml

0.79

178

1162

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

103

1.41

0.70

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

321

2162

1.08

0.70

2.0

2.6

0.23

e9/l

0.02

269

1869

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

184

0.71

0.69

5.1

5.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.70

0.69

1.0

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

192

1.29

0.69

1.2

2.9

17.23

15.30

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

124

0.65

0.69

1.2

1.5

—

(40758358) Immune stain study

141

0.67

0.68

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

110

1.39

0.68

1.1

1.0

0.16

0.14

u/ml

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

511

1.17

0.67

1.2

1.3

51.11

166.36

titre

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

241

0.76

0.67

1.3

1.45

1.52

ml/s/173m2

0.07

156

(3048879) Bone marrow aspiration report

726

0.86

0.67

1.4

2.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

324

1.21

0.67

1.0

1.1

1.70

2.83

umol/24h

0.49

324

(3044590) Delta aminolevulinate [Moles/volume] in Urine

1.82

0.66

1.0

1.1

25.00

14.15

umol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

362

0.80

0.66

1.2

1.76

1.51

mmol/l

0.07

234

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

313

2113

1.08

0.66

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

136

1.34

0.66

1.0

0.07

0.09

u/ml

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

168

1.30

0.65

1.0

1.1

44.00

50.41

u/l

0.33

132

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.61

0.65

3.9

3.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

220

1465

1.09

0.64

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

201

1.27

0.64

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

344

0.80

0.64

1.4

—

(3000012) Reticulocyte production index

515

3542

1.06

0.63

2.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.41

0.63

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

144

1169

0.90

0.63

1.7

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

116

953

0.89

0.62

2.2

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

250

1677

1.09

0.62

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

204

0.75

0.61

2.0

2.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

316

2470

0.93

0.61

18.9

18.8

1349.29

2719.59

nmol/l

1.09

305

2375

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

212

0.76

0.60

7.7

4.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

798

1.12

0.60

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

293

2294

0.93

0.59

1.8

2.0

1.89

2.35

u/field

1.02

163

1022

(3006245) CD3-CD19+ cells/100 cells in Blood

191

1270

1.10

0.59

1.8

2.2

9.06

9.99

0.89

183

1176

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

300

2346

0.93

0.59

14.6

13.4

790.85

1480.15

nmol/l

0.82

291

2269

(3034891) Synovial lining cells/100 cells in Synovial fluid

216

1445

1.09

0.59

1.4

1.5

4.13

3.99

0.05

333

(3011335) Digoxin [Mass/volume] in Serum or Plasma

194

0.75

0.58

2.8

2.2

—

(3010937) Rubella virus Ab [Presence] in Serum

243

0.78

0.58

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1557

11002

1.03

0.58

1.9

1.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

144

0.71

0.58

1.0

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1719

12880

0.97

0.58

3.2

3.4

25.07

25.28

mmol/l

2.02

1650

12484

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

160

0.73

0.57

1.1

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

218

1.24

0.57

1.1

2.19

0.91

u/ml

0.57

151

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

153

1.29

0.56

1.0

0.07

0.16

u/ml

0.67

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

153

1.29

0.56

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

501

1.15

0.55

1.5

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

346

1.18

0.54

1.0

1.1

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.48

0.54

1.1

—

358.40

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.48

0.54

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.49

0.54

2.4

2.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2091

14864

1.03

0.53

8.7

9.9

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.62

0.53

1.7

1.2

16.23

6.06

mg/l

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.60

0.53

1.0

10.08

9.32

mu/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

547

4177

0.95

0.52

2.4

2.5

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

110

1.32

0.51

1.0

1.1

0.18

0.21

g/l

1.32

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

407

3130

0.95

0.51

1.5

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

215

1.22

0.50

1.2

1.1

12.57

17.38

iu/ml

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

143

1.27

0.50

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

805

0.90

0.49

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

152

1209

0.92

0.49

2.2

2.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

212

0.79

0.48

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

155

0.75

0.48

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.36

0.48

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.50

0.48

1.1

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

380

2621

1.06

0.48

1.4

1.5

0.94

0.95

g/l

0.30

375

2606

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.43

0.48

2.0

2.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

518

0.87

0.47

2.6

2.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.32

0.47

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

211

1.21

0.46

1.3

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

129

0.73

0.46

1.0

1.1

—

(40768441) Liver Pathology biopsy report

292

2257

0.94

0.45

1.2

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

373

2577

1.05

0.45

1.5

1.8

—

(3014891) Appearance of Pleural fluid

305

0.84

0.45

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

532

1.12

0.44

1.9

2.4

6.68

7.51

mmol/l

1.46

314

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

214

1454

1.07

0.44

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

437

0.87

0.44

1.1

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

146

1.25

0.44

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

191

1293

1.08

0.44

1.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

184

1244

1.08

0.44

1.8

2.1

27.06

29.66

2.24

177

1176

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.36

0.43

1.0

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

281

2170

0.94

0.43

1.7

1.9

2.92

3.73

mg/l

4.48

268

2068

(46235168) Fasting glucose [Moles/volume] in Blood

405

0.86

0.43

1.2

1.8

6.12

7.43

mmol/l

1.67

125

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

328

1.15

0.42

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

114

1.28

0.42

1.1

1.3

1.08

1.10

u/field

0.03

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

261

1.17

0.41

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

130

869

1.09

0.41

1.5

1.4

45.34

54.48

1.93

110

739

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.35

0.41

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

126

0.75

0.41

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

339

2597

0.95

0.40

2.5

2.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

181

1.21

0.40

1.0

1.1

—

(3016228) CD19 cells/100 cells in Blood

157

1233

0.93

0.40

2.2

2.0

9.50

8.51

0.57

151

1207

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

170

1151

1.08

0.40

2.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

371

1.14

0.40

5.1

7.8

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.09

—

(3024869) Neuronal Ab [Presence] in Serum

509

1.12

0.40

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

575

4350

0.96

0.40

3.6

3.0

0.79

0.81

nmol/l

0.63

451

3340

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

948

6704

1.03

0.40

1.5

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

195

1.20

0.39

1.5

325.94

313.06

umol/24h

0.09

195

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

191

1485

0.94

0.38

1.5

1.9

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

260

0.84

0.38

1.0

1.1

22.18

21.49

u/l

0.07

174

(3029612) Listeria sp Ab [Titer] in Serum

1.32

0.38

1.6

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

370

2818

0.96

0.36

2.6

3.2

56.33

56.54

0.07

304

2404

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

346

2405

1.05

0.36

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

346

2405

1.05

0.36

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

346

2405

1.05

0.36

1.4

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

636

0.90

0.36

1.3

55.81

81.29

mu/l

0.68

473

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

638

4800

0.97

0.35

1.6

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

598

1.10

0.35

2.0

1.8

2.51

3.53

ug/l

0.44

371

(3041184) Isoniazid [Presence] in Urine

1.37

0.34

1.2

2.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.37

0.34

1.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

244

1685

1.05

0.34

1.2

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1692

12088

1.02

0.34

2.0

—

(3050794) Legionella sp Ab [Presence] in Serum

260

1.15

0.34

1.2

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.37

0.33

1.2

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.32

0.33

1.0

—

(40762814) Titanium [Mass/volume] in Blood

425

0.89

0.32

2.3

2.97

4.01

ug/l

1.37

149

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

371

0.88

0.32

1.9

2.3

0.64

0.67

u/field

0.05

371

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

378

0.89

0.31

6.3

8.4

0.32

0.40

umol/l

0.55

339

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3026

21749

1.01

0.31

2.5

2.8

156.09

182.37

ng/l

3.30

2742

19656

(3003157) Bacteria [#/volume] in Mother's milk

1.27

0.30

6.6

6.5

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.27

0.30

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.27

0.30

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

276

0.87

0.30

1.2

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

748

0.92

0.30

1.3

44.37

39.21

0.62

504

(3006576) Bicarbonate [Moles/volume] in Blood

135

921

1.07

0.29

4.4

6.4

24.58

25.15

mmol/l

0.88

129

832

(3011412) CD3 cells [#/volume] in Blood

434

3052

1.04

0.29

2.0

2.5

1.34

1.21

e9/l

1.68

378

2734

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

388

1.11

0.29

2.6

22.92

23.14

mg/l

0.05

366

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

284

2159

0.96

0.29

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

563

3979

1.03

0.29

2.4

2.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

193

1480

0.95

0.28

1.5

1.9

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.27

0.28

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.27

0.28

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.27

0.28

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.27

0.28

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.27

0.28

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.27

0.28

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.32

0.28

1.4

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

715

0.93

0.28

1.3

1.2

481.67

316.97

pmol/l

0.46

527

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

181

1389

0.95

0.27

1.1

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

577

4084

1.03

0.27

2.8

146.00

503.30

u/ml

0.81

568

4035

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

183

1.15

0.27

1.0

—

(3006462) Nitrate [Presence] in Urine

195

1492

0.95

0.27

2.4

3.0

—

(3018291) Platelet Ab [Presence] in Serum

1.21

0.27

1.1

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

280

1.12

0.26

1.2

1.3

5.37

6.15

mmol/l

0.43

136

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

541

3830

1.03

0.26

1.4

1.5

—

(3022689) Creatine [Moles/volume] in Urine

124

849

1.06

0.26

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

280

0.88

0.26

1.5

1.2

45.13

325.71

mg/24h

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

378

1.10

0.25

2.6

2.7

—

(3002619) Bacteria identified in Specimen by Culture

624

1.07

0.25

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

567

4240

0.97

0.25

1.4

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

439

0.91

0.25

1.2

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

183

1270

1.05

0.25

2.8

5.7

5700.86

2557.68

mg/l

0.65

130

907

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

124

0.82

0.24

1.0

1.5

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

110

1.19

0.24

1.1

2.33

1.03

u/field

0.39

(3036670) Protein [Mass/volume] in Synovial fluid

105

814

0.94

0.24

1.2

1.3

38.69

39.97

g/l

0.44

450

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

124

1.17

0.23

7.0

9.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

431

3049

1.03

0.23

1.4

1.7

—

(3049233) Organic acids panel - Urine

1.30

0.23

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

216

0.88

0.23

1.2

23.20

22.29

—

(3032641) Amino acids panel - Urine

1.26

0.22

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

155

1185

0.95

0.22

1.7

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

822

5868

1.02

0.22

2.0

2.3

0.86

0.85

nmol/l

0.05

694

4937

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

372

2792

0.97

0.22

1.5

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

655

4877

0.98

0.22

2.2

2.9

3435.72

6475.57

u/ml

0.40

265

(3020399) Glucose [Mass/volume] in Urine

0.00

0.22

0.0

1.5

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

712.50

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.25

0.22

1.4

1.86

2.18

mmol/24h

0.44

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

870

6457

0.98

0.21

3.9

6.0

7257.10

1142.64

iu/ml

0.46

958

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

140

970

1.05

0.21

2.3

3.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1644

11813

1.01

0.21

3.7

3.9

51.30

48.57

4.35

1622

11687

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

208

1.12

0.21

1.3

1.2

140.32

107.22

ug/l

0.46

126

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.21

0.0

1.8

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

1.21

0.20

1.0

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

440

1.08

0.20

2.6

3.0

15.22

14.87

ml/dl

0.42

411

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.79

0.20

7.4

8.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

328

2319

1.03

0.20

2.2

2.6

821.16

689.76

e6/l

3.23

314

2252

(3000285) Sodium [Moles/volume] in Blood

328

1.09

0.20

1.1

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.18

0.19

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

147

1.14

0.19

1.1

1.2

—

(3013762) Body weight Measured

136

0.86

0.19

1.1

—

(3005570) Glucose [Moles/volume] in Urine

425

3019

1.03

0.19

1.9

14.68

23.06

mmol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

905

6483

1.02

0.19

1.5

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

452

3215

1.02

0.18

1.4

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

311

2201

1.03

0.18

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

452

3216

1.02

0.18

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

1302

0.96

0.18

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

1302

0.96

0.18

1.4

1.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.19

0.18

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

513

3657

1.02

0.18

1.5

1.6

49.82

56.16

2.76

313

2331

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

514

1.06

0.18

4.6

5.8

68.64

69.56

0.12

396

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

183

1.11

0.17

1.1

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

199

1500

0.97

0.17

2.0

3.62

3.74

ug/l

0.08

188

1362

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

119

0.86

0.17

1.0

1.07

0.84

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

211

1487

1.03

0.17

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

397

2959

0.98

0.17

1.1

1.2

—

(3008607) Semen analysis panel

316

0.92

0.16

1.3

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

247

1.09

0.16

1.1

—

2.64

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.12

0.16

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

417

1.07

0.16

1.3

1.4

47.42

52.58

0.39

206

(3032868) Hemoglobin electrophoresis panel in Blood

311

1.08

0.16

1.5

1.6

—

(3037121) Protein [Mass/volume] in Urine

1383

9958

1.01

0.16

2.7

3.2

0.26

0.33

g/l

2.43

555

4401

(3012565) Volume of 24 hour Urine

213

1504

1.03

0.16

2.0

2.2

2032.08

1989.78

0.18

191

1356

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.21

0.15

1.0

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

772

5709

0.98

0.15

1.4

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.15

0.15

3.4

2.6

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.15

0.15

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

136

1.12

0.15

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

196

1473

0.97

0.15

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

329

2340

1.02

0.15

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

643

0.95

0.15

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.18

0.15

1.0

1.4

176.50

131.04

nmol/l

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.09

0.15

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

0.81

0.15

1.1

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.17

0.15

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

200

1.09

0.14

1.5

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1204

8866

0.99

0.14

2.4

2.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

181

1359

0.97

0.14

1.2

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

163

1226

0.97

0.14

2.5

2.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

181

1358

0.97

0.13

1.2

1.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

406

1.06

0.13

2.3

2.6

43.95

74.55

pmol/l

2.18

347

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

484

0.95

0.13

1.1

1.86

3.42

pmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

343

1.06

0.12

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

443

1.05

0.12

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

195

1.08

0.12

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

309

1.06

0.11

1.1

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

341

2439

1.02

0.11

2.0

2.1

74.77

73.25

1.62

327

2345

(3004451) EKG impression Narrative

168

1256

0.97

0.11

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

182

1.08

0.10

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

196

1461

0.98

0.10

2.0

2.1

2.25

2.45

ug/l

0.38

167

1217

(3001964) Herpes simplex virus Ag [Presence] in Specimen

131

982

0.97

0.10

1.3

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

316

2262

1.02

0.10

1.9

2.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

332

1.05

0.10

2.3

2.7

1.00

1.12

mmol/l

0.15

227

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

418

1.05

0.10

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5679

41498

1.00

0.09

2.8

2.7

0.64

0.73

ug/l

5.89

3423

24963

(3044416) Complement C4 [Mass/volume] in Pleural fluid

121

0.90

0.09

1.3

1.1

0.05

0.07

g/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

494

3553

1.01

0.09

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

194

1442

0.98

0.09

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

735

0.97

0.08

2.1

2.6

95.29

100.68

ng/l

0.14

369

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

443

3266

0.99

0.08

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.81

0.08

1.0

1.1

1144.00

1973.78

titre

—

(3044316) Mercury [Moles/volume] in Urine

0.81

0.08

1.6

2.5

5.42

11.57

nmol/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

277

1.05

0.08

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.12

0.08

4.3

5.6

0.21

0.22

mmol/l

0.03

(3026726) Creatinine [Moles/volume] in Specimen

224

0.94

0.08

2.1

2.4

513.59

397.34

umol/l

0.22

216

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

104

0.91

0.07

1.2

1.1

255.31

261.64

nmol/l

0.05

104

(3027923) C peptide [Moles/volume] in Serum or Plasma

221

1633

0.99

0.06

1.7

1.6

1.22

1.25

nmol/l

0.19

170

1304

(3018133) Calcium [Moles/volume] in Urine

473

0.97

0.06

1.5

1.8

2.32

2.74

mmol/l

1.10

428

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

473

0.97

0.06

4.0

4.7

46.61

44.00

ug/min

0.10

372

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

122

1.07

0.06

26.7

15.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

287

1.04

0.06

2.0

2.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

165

1.06

0.06

1.1

1.2

—

510.00

—

(3051593) INR in Capillary blood by Coagulation assay

156

1118

1.02

0.05

6.4

9.9

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

132

0.94

0.04

1.0

0.77

0.24

u/ml

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

525

3799

1.01

0.04

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

333

2405

1.01

0.04

1.9

2.1

13.63

14.71

1.51

325

2338

(3042631) Mycobacterium sp identified in Specimen

481

3526

0.99

0.04

2.8

2.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

1648

0.99

0.04

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

174

1.05

0.04

1.5

1.7

—

(3010503) CD19 cells [#/volume] in Blood

253

1857

0.99

0.03

2.2

2.7

0.17

0.32

e9/l

1.65

243

1816

(3033086) Enterovirus NOS Ab [Titer] in Serum

110

1.06

0.03

1.1

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1062

7711

1.00

0.03

2.5

3.3

7.68

3.69

ratio

0.36

100

588

(3002331) Protein [Mass/volume] in Peritoneal fluid

570

0.98

0.03

1.3

1.4

27.84

28.54

g/l

0.08

439

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

167

0.96

0.03

1.3

2.23

1.55

mg/l

0.94

140

(21494815) CD4 cells/100 lymphocytes in Specimen

378

2767

0.99

0.02

2.1

2.2

42.21

38.84

4.71

370

2720

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

125

1.05

0.02

1.0

0.59

0.43

u/ml

—

(3024316) Viscosity of Plasma

140

1.04

0.02

2.1

1.5

1.69

1.48

mpas

1.10

(3034860) Kappa light chains.free [Mass/volume] in Serum

1091

7958

1.00

0.01

2.6

3.4

41.02

69.00

mg/l

2.07

867

6448

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

202

0.97

0.01

1.1

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.07

0.01

1.0

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

141

1.03

0.01

1.5

0.00

0.16

u/l

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

247

1794

1.00

0.00

1.4

12.29

12.42

u/l

0.10

240

1736

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.01

0.00

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

106

1.03

0.00

1.1

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.00

0.00

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

157

0.97

0.00

1.5

1.7

0.65

0.71

umol/l

0.26

117

(3027874) Urate [Moles/volume] in Urine

1.03

0.00

1.0

1.1

1.91

8.91

mmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

410

0.99

0.00

1.3

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

438

1.00

0.00

1.2

1.80

1.75

mmol/l

0.05

270

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

448

0.99

0.00

1.1

1.3

35.71

41.60

mg/l

0.55

386

(3014271) Vancomycin [Susceptibility]

168

1224

1.00

0.00

2.7

3.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

642

4675

1.00

0.00

1.4

1.7

—

(3034426) Prothrombin time (PT)

162

1179

1.00

0.00

1.3

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

642

4676

1.00

0.00

1.4

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

216

1571

1.00

0.00

6.8

6.2

535.23

3132.39

u/ml

0.71

330

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1090

7940

1.00

0.00

2.6

3.4

38.50

41.42

mg/l

0.17

872

6432

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.03

0.00

1.1

1792.83

4582.41

ng/l

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

0.0

2.4

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.98

-0.00

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.95

-0.00

1.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.94

-0.00

1.0

1.1

2.50

2.55

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.99

-0.00

1.0

1.1

1.00

1.22

u/field

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.0

—

2.75

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_INSOMNIA – Insomnia

GWS hits: 9

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Insomnia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Insomnia (F5_INSOMNIA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints